CA2007562A1 - Reinforced graft assembly - Google Patents
Reinforced graft assemblyInfo
- Publication number
- CA2007562A1 CA2007562A1 CA002007562A CA2007562A CA2007562A1 CA 2007562 A1 CA2007562 A1 CA 2007562A1 CA 002007562 A CA002007562 A CA 002007562A CA 2007562 A CA2007562 A CA 2007562A CA 2007562 A1 CA2007562 A1 CA 2007562A1
- Authority
- CA
- Canada
- Prior art keywords
- component
- graft
- reinforced
- fibers
- assembly according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
Abstract
REINFORCED GRAFT ASSEMBLY
Abstract of the Disclosure A reinforced graft assembly made from a vascular graft component and a reinforcing sleeve component. The reinforcing sleeve component may include one or more layers. The diameter of the inner surface of the most internal layer of the reinforcing sleeve component is approximately equal to or larger than the diameter of the vascular graft component thereby allowing the former to be fitted over the latter. The compliance of the sleeve component is adjustable depending on the application needs, for example, by varying the angle at which the fibers used to form the sleeve component are laid down and by the method used to join the two components.
Abstract of the Disclosure A reinforced graft assembly made from a vascular graft component and a reinforcing sleeve component. The reinforcing sleeve component may include one or more layers. The diameter of the inner surface of the most internal layer of the reinforcing sleeve component is approximately equal to or larger than the diameter of the vascular graft component thereby allowing the former to be fitted over the latter. The compliance of the sleeve component is adjustable depending on the application needs, for example, by varying the angle at which the fibers used to form the sleeve component are laid down and by the method used to join the two components.
Description
~-- z~
:` 756Z
PATENT ::
Case 880705 IR 88037 ~ .
REINFORCED GRAPT ASSEMBLY
5De~cri~tion ~ `
' .
Backqround and DescriPtaon of the Inventlon :: ~
The present invention genera}ly relates to : . :
a graft. More particul~rly, the invention rela~es to a graft, Cuch as a vascular graft, constructed fro~
two componentss a synthetic, blologic or biosynthetic vascular graft component and a reinforclng sleeve component, each of which h~s ~n appropriately aized intern~l diameter ~o the graft 15 component may be fitted ~ithin the sleeve co~ponent. ¦, In the medical treatment of patien~s with diseased arteries or veins, surgeons mzy replace the failing ti88ue ~ith prosthetic conduits ~uch as ~ascular grafts. Conventional grafts~ h~ever, can : ~
20 kink or collapse mechanlcally und~r a variety of ~ -circumsta~ce~ such as ~ben the graft i~ b~nt during the contr~ction oS the surrounding ~uscle, or ~ben e~ternal pressure i~ applied to the gra~t durlng a period of rest taken by the reclpient o~ the gr~ft.
25 One conventional solution to the~e proble~s has con~iste~ o~ the reinforceMent of the ~ o væscular gr~f t8 by the ~eak attachmen~ of eith~r ! `:
di~crete poly~eric ring~ or contlnuo~s spir~
poly~eric band~ to ~ portion~ albeit often a sDall ~:
30 portio~, of the e~terior su~ce o tb~ pro~the~is. I. ;
Gr~t~ to ~bich ~uch li~ited r~n~orcing :~
rlng~ or b~nd~ ar~ attaeh~d have cert~in li~ tlo~s.
0~ it~tio~ of oon~ntio~ally r~in~orccd va~icul~
gr~ft~ i~ t~at th~ r~ or¢lng ~e~b~r ~ay lntorfl~r~ i .;
35 ~ith tbc cre~tion o~ ~n ~ to~o~i~. In 8UC~ ai~e~ `:
tb~ reinor~æ~ot ~u~ b~ ~y~ lly r~s~d by ~00756z ~;~
:` 756Z
PATENT ::
Case 880705 IR 88037 ~ .
REINFORCED GRAPT ASSEMBLY
5De~cri~tion ~ `
' .
Backqround and DescriPtaon of the Inventlon :: ~
The present invention genera}ly relates to : . :
a graft. More particul~rly, the invention rela~es to a graft, Cuch as a vascular graft, constructed fro~
two componentss a synthetic, blologic or biosynthetic vascular graft component and a reinforclng sleeve component, each of which h~s ~n appropriately aized intern~l diameter ~o the graft 15 component may be fitted ~ithin the sleeve co~ponent. ¦, In the medical treatment of patien~s with diseased arteries or veins, surgeons mzy replace the failing ti88ue ~ith prosthetic conduits ~uch as ~ascular grafts. Conventional grafts~ h~ever, can : ~
20 kink or collapse mechanlcally und~r a variety of ~ -circumsta~ce~ such as ~ben the graft i~ b~nt during the contr~ction oS the surrounding ~uscle, or ~ben e~ternal pressure i~ applied to the gra~t durlng a period of rest taken by the reclpient o~ the gr~ft.
25 One conventional solution to the~e proble~s has con~iste~ o~ the reinforceMent of the ~ o væscular gr~f t8 by the ~eak attachmen~ of eith~r ! `:
di~crete poly~eric ring~ or contlnuo~s spir~
poly~eric band~ to ~ portion~ albeit often a sDall ~:
30 portio~, of the e~terior su~ce o tb~ pro~the~is. I. ;
Gr~t~ to ~bich ~uch li~ited r~n~orcing :~
rlng~ or b~nd~ ar~ attaeh~d have cert~in li~ tlo~s.
0~ it~tio~ of oon~ntio~ally r~in~orccd va~icul~
gr~ft~ i~ t~at th~ r~ or¢lng ~e~b~r ~ay lntorfl~r~ i .;
35 ~ith tbc cre~tion o~ ~n ~ to~o~i~. In 8UC~ ai~e~ `:
tb~ reinor~æ~ot ~u~ b~ ~y~ lly r~s~d by ~00756z ~;~
peeling or cutting t off the graft at the time of surgery. Another li~itation is that, becau~e the reinforcement i8 confined to certain areas of the graft, the reinf orcement may not necessarily coincide with the area where the reinforce~ent protection i~
~ctually needed. Thi~ may happen where the ~o~t desirable site to create the pro~imal and di~tal anastomosis i8 in an area of ~he patient which anatomically presents dif~iculties to the placement of the reinforced graft. An additional limitation iY
that the stiffness of the reinforcing ~ember may reduce the ci rcumf erential and/or longitudinal co~pliance of the graft. A non-compliant gr~ft ~ill ~educe the pulsatile flow through the graft tbereby co~p~omi~ing the ability o the prosthesis to perfor~
naturally. Pourth, the rein~orcing ~e~bers of conventional vascular graf ~8 bave a smooth and non-porous surface. Such a aurface cannot be penetrated by cellular growth and, accordingly, represents a biologically i~co~patible interface between the graft and the ho~t tisaue. This inco~patibility may cau~e the ero~ion oS the ~u~rounding ti~sue, the or~tion o~ undesirable burs~e ~nd fibrotic capsule~, or the for~ation of calcium deposits.
~ he present invention includes a ~o-co~ponent syste~, one co~ponent of ~hich, the graft componen'c, co~-prise~ a ~ynthetic, biologic or biosynthetic graft, including the type detailed in D.S. Patent ~o. ~,355,~26 ~o ~aoGregor and, i~ pnrt, in V.8. P~ltent llo. 4,7~3,252 to ~artin and ~aGregor and f~bric~ted i~ the ~anne~ detailed i~ ~.S. Patent No. 4,~7S,972 to ~ong. Theae pnt~nts are in¢o~porated ~y ~efer~nce h~ to. Th~ oth~
oo~po~e~, tho sle~ c0~2~t ~y ba ~o~e~ r~
~ynth~tl¢, blologic~ or blo~y~th~t~ ~at~lal. Sh~
Z!)07562 - ~
:
,`
~ctually needed. Thi~ may happen where the ~o~t desirable site to create the pro~imal and di~tal anastomosis i8 in an area of ~he patient which anatomically presents dif~iculties to the placement of the reinforced graft. An additional limitation iY
that the stiffness of the reinforcing ~ember may reduce the ci rcumf erential and/or longitudinal co~pliance of the graft. A non-compliant gr~ft ~ill ~educe the pulsatile flow through the graft tbereby co~p~omi~ing the ability o the prosthesis to perfor~
naturally. Pourth, the rein~orcing ~e~bers of conventional vascular graf ~8 bave a smooth and non-porous surface. Such a aurface cannot be penetrated by cellular growth and, accordingly, represents a biologically i~co~patible interface between the graft and the ho~t tisaue. This inco~patibility may cau~e the ero~ion oS the ~u~rounding ti~sue, the or~tion o~ undesirable burs~e ~nd fibrotic capsule~, or the for~ation of calcium deposits.
~ he present invention includes a ~o-co~ponent syste~, one co~ponent of ~hich, the graft componen'c, co~-prise~ a ~ynthetic, biologic or biosynthetic graft, including the type detailed in D.S. Patent ~o. ~,355,~26 ~o ~aoGregor and, i~ pnrt, in V.8. P~ltent llo. 4,7~3,252 to ~artin and ~aGregor and f~bric~ted i~ the ~anne~ detailed i~ ~.S. Patent No. 4,~7S,972 to ~ong. Theae pnt~nts are in¢o~porated ~y ~efer~nce h~ to. Th~ oth~
oo~po~e~, tho sle~ c0~2~t ~y ba ~o~e~ r~
~ynth~tl¢, blologic~ or blo~y~th~t~ ~at~lal. Sh~
Z!)07562 - ~
:
,`
graft component comprises a porous kurface and a network of interconnected interstitial pores below the surface, which network is in fluid flow communication with the surface pore~.
The second component of the two-component system of the present invention includes a reinforcing sleeve com~onent. Like the graft component, ~he ~econd component includes a porous surf~ce and a porous sub~urface. The ~leeve component has an inter~al diameter ~hat i8 egual to or larger th~n the external diameter of the graft co~ponent and, as Cuch i~ ~ized 80 that it may be fitted over the fir~t component of the present inventlon.
The two-component system of the present invention provide~ advantageously a syste~ which, while prov$ding reinforcement to a graft, overcomes the lL~itation~ as~ociated with conventional graft ;~
reinfo~ce~nt ~ystems. Por e~a~ple, by separating the graft co~ponent fro~ the reinforcing sleeYe co~ponent, the blood transporting function handled by the former i8 isolated from the ~echanic~l load bearing function handled by the l~tte~. ThiB
i~olation act~ to preserve the inherent co~pliance of the blood tr~nsporting member. A non-conpl~ant blood transporting ~ember wlll inter~ese with nnd break up ~
the natural wave flow of in vi~o blood, which i8 a ;;
seriou~ di3adv~nt~ge of prior art reinforced grafts.
Generally ~po~k~ng, prior art reinorced vascular grafts ca~ reduce the pulsatile ~lo~ o blood there~hrough by A factor of 80~e 10 to 30 p~rcent. . ~
~h~ t~o-co~ponent ~yste~ of the present ;-in~ntlon al~o ~ W8 the ~eparAte reinforcing ~lee~e co~ponent to b~ l~c~e~ at i~y positio~ ~long t~e length of th~ pro~L~si- or essn ~cro~ ia~
~na~to o-i- th~r~by pro~ldl~g ~upp~rt to ~ loc~liæed .
;~00756;~ ;`
.
section of the graft or host artery. For e~a~ple, during the course of surgery~ the ~lidable i reinforcing sleeve according to this invention can be j precisely located to provide needed reinforcement at Z~ 5 a precise loc~tion, such as acros~ a knee joint, a rib cage or the like.
A two-component ~y~tem, as in the present invention, in which the graft component i8 rein~orced by a sleeve compon~nt, also may be fitted into a 10 restricted area without reguiring the removal of the seg~ented reinforcing rings or band~ taught in conventional reinforced vascular grafts.
Additionally, because the reinforcing ~leeve cooponent may be fi~ed over the graft co~ponent ..
15 through a ~ariety of mean~, and the oeans choaen to accomplish the fixation affects to a certain degree 1 the co~pli~nce, the resultant compliance of the ;Z reinforced graft asse~bly i5 adju~table. In J addition, cODpliance i8 adjustable by winding the .~ 20 fiber~ of the reinforcing sleeve compohent at an ~'Z angle ~hich enhances kink re~i~tance. Co-lpliance i8 I also adjust~ble by vary$ng the duro~eter hardnes~ of the fibers fro~ which the reinforclng sleeve ! col~ponent i~ ~-ade.
The structure of the present invention aids ; in renderlng the invention bioco~patible ~nd hemocompatible and f~cilit~ites its fi~tion uithin :~ the body. The ~or~er adv~ntage is reali2ed due to ~.
the porou0 sllr~Eace ~nd sub~urface net~ork 30 chl~racterising tbe structure of the invention. Thl8 .-i, structure encour~ges cellulglr ingrowth ~n~ OW8 a ootb, tb$n ti~ue co~ting to forD~ and to ~dhere to ~-1 tbe porou~ surf~ce of tbe present inrention.
De~irably, this coating r~ r~ the gragt r~ ~Z~t ,~i 35 to tb~ or-at~,on of blood clo~ ich sr~ allr ;1 ~s~ociat~d ~ the pr~aanc~ og forelgn bodi , l~uch ,, ,~ Z.')~7562 . ~
:
a~ graf ts or prosthese~ the blood stream. The : .
latter Phenomenon, that i8, the fiYation of the strengthened graft to ~he adjacent l:issuec~ i~ cau ed also by the for~ation of the adherent ti88ue coating on the porous surf ace. It allow~ the i~plant to be incorporated into the cardiovascular 8y8tem thereby achieving a more secure attachment than previou~ly ; .
obtainable. ! ~ - ~
It i6, accordingly, a general object of the present invention to provide an i~proved graft.
Another object of tb~ present invention i8 ~ `
to provide an improved gr~ft ~sQembly havinq a compliant inner graft component and a reinforcing sleeve component that does not substantially 15 interfere with the compliant properties of the inner :
graft co3ponent. ~:
Additionally, it i~ an object of this ::~
inven~ion to provide an i~pro~ed reinforced qraft who6e overall compliance i8 ~djustable.
~nother object o this invention i8 to provid~ an i~proved reinforced graft and ~ethod of makîng sa~e.
The~e and othe~ object~, features and , : *
advantages o~ this invention ~ill be clearly understood th~ough a consideration o~ the followin~
detailed description. ~:
Brief Descri~tion of the Dra~inq~
I~ the course of this deacriptio~, :::
referenc~ will be ~ade to the ~ttached dra~ings, :~
30 ~here~n: 3 ~;
Figure 1 i~ n pe~sp~cti~e vie~, partially I ~::
broken a~2y, of a kno~n graft co~p~nent æuitable or incluBion in the as~el~bly a~:cordlng to tho pre~c~
inventiont ~igur~ 2 iæ ~ p2r~pecti~e ~ , part~lly cut a~Ay~ o one e~b~a~-ent o ~ r~ orei~g ~l~ev~ ~
., .
: ~, .~ z~75~z component according to this in~ention into which the graft component illustrated in ~igure 1 ~ay be fitted;
Figure 3 is a perspective view, partially broken away, of another embodiment of a reinforcing sleeve component accordi~g to this invention into which the graft component illu~trated in Figure 1 ~ay be fitted;
Figure ~ i~ a cut away peespective view illustrating a cross-section of the reinforcing sleeve component shown in ~igure 2 in which the component i~ protected from biodegration by spinning the fiber~ which ~orm the internal layer and the external layer beyond the lntermediate layer ribbon or ~ilament;
Figure 5 i8 a cut away perspective view similar to Figure ~ and in whic~ biodegrad~tion prevention o the reinforcing slee~e componen~ i~
further enhanced by applying a ~oft polymer to the ends of the polymeric ribbon or filament of the inter~ediate layer of the 2~bodi~ent illustrated in Figure 25 and Figure 6 i8 a cut aw~y perspective vi~w which illustrates another e~bodi~ent ~or preYenting biodegradation of the reinforcing ~leeve co~poncnt.of the e~bodiment illustrated in Figure 2 by ~nicuring i.
the ends of the poly~eric ribbon or ~ilament of the inter~diate l~yer.
D~cription_of tbe PaEt~CU1~r ~bodi~ents ~ 30 The presen~ en~ion typically i3 a : two-co~ponent ~se~bly of ~ synthetic~ biolcgic or bio~ynth~t~c gr~t ~o~po~en~ c~ generally ~no~n type togeth~r ~1 ~ n~ e~t~rnal r~in~orcing ~l~eve co~pon~nt~ Tbe g~ag~ illu~tr~t~ i~ the dr~ng~ i8 3 5 a Ya~ql~r graft co pon~nt.
2007~
The pre~erred qraf t component i~
illustrated in Figure 1 and is generally designated by reference numeral 11. Graft component 11 has a porous surface 12 and a network 13 of interconnec ed interstitial pores below the surface which are in fluid flow com~unication with the ~urf~ce 12. ~hen the device i~ i~planted, the porous surface 12 and the ~ubsurf~ce network 13 promote cellular ingrowth and the formation of a s~ooth, thin, adherent tis~ue coating, not shovn, on th~ porous surface 12. This coating renders the graft component 11 bioco~patlble and he~oco~patible and specifically ~11OWB the surfDce 12 to remain resistant to the for~ation of blood clot8 ~nd the like normally as~ociated with the presence of foreign bodies, such as grafts or prostbeses~ in the blood stream~ Additionally, the coating facilitates a ~ecore attach~ent of the graft :~ -into ~be cardiovascular ~yste~
The methods by ~hich the graft component 11 may be fabricated include those disclosed i~
Pate~t ~o. ~,~75,972. In one fabrication method disclosed in ~.S. Patent ~o. ~,~75,972, and termed BolUtion processing~, a biocomp2tible polymeric ~ater1al, such ~8 biocompatible polyureth~ne, i8 dissolved in a suitabl~ solvent, such as diDethyl for~a~ide, to form a v:Lscous sQlution. The resultant ~wet~ solution i~ puJped under pressure into a ; didtributor and out tb~ouq~ one or ~ore orifices to for~ one or ~ore continuous fi}a~en~ of tubular :-~ate~i~l. ffl e e~truded fi~er or ibor~ are placed in cont~c~ ~ith ~ rot~ting ~andr~l. Because the eyt~rior d~ai~tes ~iYe of the ~ndr~l ~ill deter~ine the inn~ dl~et~r 31s~ of tbe gra~ ~o~po~ot 11, ~ : .
g~gt o al~o~t a~y l~tarnal dia e~ nay be o~de by choo~lng a ~a~dr&~ of ~h~ approp~l~t4 ~
Th~ trlbutor or spln~r~tt~ reelproc~te~ fro~ O~Q
", ; .
"- Z(~075~Z
axial end of ~he mandrel to the other 90 that the fibers are wound onto the mandrel in different and OppO 8i te direction~.
The conditions of the winding proceP6 are S critical for purposes of opti~i~ing t:hose characteristics which directly affect the p*rformance of the graft component 11. On~ such ~haracteristic i8 the compliance of the graft component 11. This characteristic may be varied by selecting the appropriate diameter of the fiber ~ro~ which the graft oomponent 11 i8 for~ed. The circumferential speed of the rotating mandrel will deter~ine to what degree the fiber extruded in contact with the m,~ndrel will stretch. The greater the stretch, the s~aller the diamete~ of the ~iber and the greater the fle~ibllity and compliance of the resultant graft.
Compliance may also be varied according to the angle at which the f iber used to for~ the graft component ~ ~ .
11 i8 wound. Radial compliance varieR on an inverse proportional basis to the angle of winding, with a les co~pli~nt ~raft made by increasiAg the angle of winding, defined as an acute angle ~ith r~pect to the a~is of the graft or oandrel on which it iA
wound.
~Xink re~i3tance~, that iR, the ability of the graft to be bent without gre~tly reducing the croso-~ectional area of the inside of the gr~ft, i8 anotber chnr~cteristlc which D~y be varied by t~e angle at ~blch the fibær for~ing the gr~t co~ponent 30 11 iff ~ound. ~ graft ~ltb little ~kink re~istanc~
will ~ink with only llttle bending o~ the grat thereby stopping the flo~ o~ blood. Tbe larger the ~nql~ of ~lndi~g~ the gre~te~ the abllity of the gr~t to ~ith~nd fle~ing ~i~bout ~lnki~g, a~d the 35 ~ore u~ful t~ gr~ft 18 for applic~tion i~ losatlons ~hl~h ~y b~ sub~ct~d to ~uch fle~l~g.
~ - ~o :
-9- ~;
The poroQity and the shape of the pore~ of ~
th~ graft dependq al80 on the angle at which the ;:
fiber i8 wound onto the mar~drel. Specifically, a -~
smaller angle of ~inding will produce a ~maller pore 5 size and reduced porosity. The ~pinnerette i~
allowed to reciprocate with re~pect to the ~andrel .,.~.;~;.
until the desired thickne~s of overlayed f ilament~ i8 obtained. When desired, the ~ilaments ~8y be extruded f rom the mandrel ~wet, and upon ev~poration of the solvent, the fila~ent~ Gecurely bond to each other at the point of overlap. A stable and non-woven structure result~ without the need for ~dditlonal proces~$ng.
While spinnable polyurethane materials are -preferred, the graft may al80 be made from other polymeric materials, such as polyolefin~ including polyethylene. With zuch polyl-eric materials, the .:
spinnerette ~ay be heated to produce tacky, fusible, and substantially solven~-free f ibers which bond to ~ :
20 each otber on the mandrel as the fiber~ cool.
Alternatively, the ~andrel ~ay be heated to use :' fibers ~18 they are laid on ~ach other ~
The reinforcing sleeve co~ponent according :
to the present invention 1~ illustrated in Piqure 2 through Figure 6. Thi~ co~ponent includes one or more layers which for~ a sleeve that i~ suitable for ~.
fitting over the graft co~ponent of th~ graft ~ :
asse~bly accord~ng to the invention.
One e~bodi~nt of t~e rei~foro$ng sleeve co~ponent according to the pre~ent inv~ntio~, ~, de~ignated 20 ~n Pig~re 2, include~ three layer~s i flrst or ~t2rna1 l~yer 21~ ~ se~ond or lntes~ed~ate l~yer 31S ~d ~ third cr ~ter~l layer ~ e in1:ern~ y-r 21 any b~ f orDed f ro~ ~y~bet~, 35 blologl~, or bioq?~thetlc and ge~rally bio~o~patl~
~at~ri~ ~<:cord~ng ~o ~h~ ~thod taught in , ~ ........... . .
. .
~ Z~)0756i~
-10- ~
:
Patent No. 4,475,972 (as generally described above) and from fibers 24 which ~ay ~ange f,rom about 1 micron to about 100 ~icrons and preferrably from S to ~ :
30 microns in diameter. ~he resultant internal layer 21 has an inner cylindrical surface ;22 who~e diameter is equal to or greater than the esterior dia~eter of the mandrel, not shown, on which the internal layer 21 i8 formed.
Onto the outer cylindrical sur~ace 23 of the internal layer 21, nn inter~ediate layer 31 may be wound. ~he inter~ediate layer ~ay be for~ed fro~
fibers of a biocompatible material according to the method taught in U.S. P~tent ~o. ~,475,972.
Preerably, the fibers are in the ~hape of a ribbon or f ilament 3~ which i8 generally flat or rect~ngular in cro~s ~ection, thereby enhancing the ~tiffness of the eleeve component 20. The fibers of thi~
intermediate layer 21 could be generally circular, depending upon the particular stiffne 8 propertie~ :
th~t are needed for the 61eeve co~ponent 20. ~he ribbon or fila~ent 3~ ound at an angle r~nging fro~ 35 to 85 w~th re~pect to th~ com~o~
longitudinAl ~ of the reinforced vascular gr~ft 20 and ~ay h~ve a dia~ter ~bicb ~y range i~ si~e fro 300 to 3,000 microns and preferably 500 to 1,000 microns .
An e~ternal layer ~1 ~ay be fabricated and laid over the out2r AUrf -CO 33 0~ tbe inter~ediate laye~ 31 according ~o tbe ~ethod~ disclo~ed in ~.S, 30 Pd~. ~o. ~,~75,972 aad as d~scu3sed ~bove.
Biocoapatible ~aterial in th~ gor~ of f~ber~
~$cron to 100 ~icro~s ~d pref~r~bly 5 to 30 ~icro~
in dia~e~er ~ay bo u~d to ~a~ the e~te~al layer ~:
The second component of the two-component system of the present invention includes a reinforcing sleeve com~onent. Like the graft component, ~he ~econd component includes a porous surf~ce and a porous sub~urface. The ~leeve component has an inter~al diameter ~hat i8 egual to or larger th~n the external diameter of the graft co~ponent and, as Cuch i~ ~ized 80 that it may be fitted over the fir~t component of the present inventlon.
The two-component system of the present invention provide~ advantageously a syste~ which, while prov$ding reinforcement to a graft, overcomes the lL~itation~ as~ociated with conventional graft ;~
reinfo~ce~nt ~ystems. Por e~a~ple, by separating the graft co~ponent fro~ the reinforcing sleeYe co~ponent, the blood transporting function handled by the former i8 isolated from the ~echanic~l load bearing function handled by the l~tte~. ThiB
i~olation act~ to preserve the inherent co~pliance of the blood tr~nsporting member. A non-conpl~ant blood transporting ~ember wlll inter~ese with nnd break up ~
the natural wave flow of in vi~o blood, which i8 a ;;
seriou~ di3adv~nt~ge of prior art reinforced grafts.
Generally ~po~k~ng, prior art reinorced vascular grafts ca~ reduce the pulsatile ~lo~ o blood there~hrough by A factor of 80~e 10 to 30 p~rcent. . ~
~h~ t~o-co~ponent ~yste~ of the present ;-in~ntlon al~o ~ W8 the ~eparAte reinforcing ~lee~e co~ponent to b~ l~c~e~ at i~y positio~ ~long t~e length of th~ pro~L~si- or essn ~cro~ ia~
~na~to o-i- th~r~by pro~ldl~g ~upp~rt to ~ loc~liæed .
;~00756;~ ;`
.
section of the graft or host artery. For e~a~ple, during the course of surgery~ the ~lidable i reinforcing sleeve according to this invention can be j precisely located to provide needed reinforcement at Z~ 5 a precise loc~tion, such as acros~ a knee joint, a rib cage or the like.
A two-component ~y~tem, as in the present invention, in which the graft component i8 rein~orced by a sleeve compon~nt, also may be fitted into a 10 restricted area without reguiring the removal of the seg~ented reinforcing rings or band~ taught in conventional reinforced vascular grafts.
Additionally, because the reinforcing ~leeve cooponent may be fi~ed over the graft co~ponent ..
15 through a ~ariety of mean~, and the oeans choaen to accomplish the fixation affects to a certain degree 1 the co~pli~nce, the resultant compliance of the ;Z reinforced graft asse~bly i5 adju~table. In J addition, cODpliance i8 adjustable by winding the .~ 20 fiber~ of the reinforcing sleeve compohent at an ~'Z angle ~hich enhances kink re~i~tance. Co-lpliance i8 I also adjust~ble by vary$ng the duro~eter hardnes~ of the fibers fro~ which the reinforclng sleeve ! col~ponent i~ ~-ade.
The structure of the present invention aids ; in renderlng the invention bioco~patible ~nd hemocompatible and f~cilit~ites its fi~tion uithin :~ the body. The ~or~er adv~ntage is reali2ed due to ~.
the porou0 sllr~Eace ~nd sub~urface net~ork 30 chl~racterising tbe structure of the invention. Thl8 .-i, structure encour~ges cellulglr ingrowth ~n~ OW8 a ootb, tb$n ti~ue co~ting to forD~ and to ~dhere to ~-1 tbe porou~ surf~ce of tbe present inrention.
De~irably, this coating r~ r~ the gragt r~ ~Z~t ,~i 35 to tb~ or-at~,on of blood clo~ ich sr~ allr ;1 ~s~ociat~d ~ the pr~aanc~ og forelgn bodi , l~uch ,, ,~ Z.')~7562 . ~
:
a~ graf ts or prosthese~ the blood stream. The : .
latter Phenomenon, that i8, the fiYation of the strengthened graft to ~he adjacent l:issuec~ i~ cau ed also by the for~ation of the adherent ti88ue coating on the porous surf ace. It allow~ the i~plant to be incorporated into the cardiovascular 8y8tem thereby achieving a more secure attachment than previou~ly ; .
obtainable. ! ~ - ~
It i6, accordingly, a general object of the present invention to provide an i~proved graft.
Another object of tb~ present invention i8 ~ `
to provide an improved gr~ft ~sQembly havinq a compliant inner graft component and a reinforcing sleeve component that does not substantially 15 interfere with the compliant properties of the inner :
graft co3ponent. ~:
Additionally, it i~ an object of this ::~
inven~ion to provide an i~pro~ed reinforced qraft who6e overall compliance i8 ~djustable.
~nother object o this invention i8 to provid~ an i~proved reinforced graft and ~ethod of makîng sa~e.
The~e and othe~ object~, features and , : *
advantages o~ this invention ~ill be clearly understood th~ough a consideration o~ the followin~
detailed description. ~:
Brief Descri~tion of the Dra~inq~
I~ the course of this deacriptio~, :::
referenc~ will be ~ade to the ~ttached dra~ings, :~
30 ~here~n: 3 ~;
Figure 1 i~ n pe~sp~cti~e vie~, partially I ~::
broken a~2y, of a kno~n graft co~p~nent æuitable or incluBion in the as~el~bly a~:cordlng to tho pre~c~
inventiont ~igur~ 2 iæ ~ p2r~pecti~e ~ , part~lly cut a~Ay~ o one e~b~a~-ent o ~ r~ orei~g ~l~ev~ ~
., .
: ~, .~ z~75~z component according to this in~ention into which the graft component illustrated in ~igure 1 ~ay be fitted;
Figure 3 is a perspective view, partially broken away, of another embodiment of a reinforcing sleeve component accordi~g to this invention into which the graft component illu~trated in Figure 1 ~ay be fitted;
Figure ~ i~ a cut away peespective view illustrating a cross-section of the reinforcing sleeve component shown in ~igure 2 in which the component i~ protected from biodegration by spinning the fiber~ which ~orm the internal layer and the external layer beyond the lntermediate layer ribbon or ~ilament;
Figure 5 i8 a cut away perspective view similar to Figure ~ and in whic~ biodegrad~tion prevention o the reinforcing slee~e componen~ i~
further enhanced by applying a ~oft polymer to the ends of the polymeric ribbon or filament of the inter~ediate layer of the 2~bodi~ent illustrated in Figure 25 and Figure 6 i8 a cut aw~y perspective vi~w which illustrates another e~bodi~ent ~or preYenting biodegradation of the reinforcing ~leeve co~poncnt.of the e~bodiment illustrated in Figure 2 by ~nicuring i.
the ends of the poly~eric ribbon or ~ilament of the inter~diate l~yer.
D~cription_of tbe PaEt~CU1~r ~bodi~ents ~ 30 The presen~ en~ion typically i3 a : two-co~ponent ~se~bly of ~ synthetic~ biolcgic or bio~ynth~t~c gr~t ~o~po~en~ c~ generally ~no~n type togeth~r ~1 ~ n~ e~t~rnal r~in~orcing ~l~eve co~pon~nt~ Tbe g~ag~ illu~tr~t~ i~ the dr~ng~ i8 3 5 a Ya~ql~r graft co pon~nt.
2007~
The pre~erred qraf t component i~
illustrated in Figure 1 and is generally designated by reference numeral 11. Graft component 11 has a porous surface 12 and a network 13 of interconnec ed interstitial pores below the surface which are in fluid flow com~unication with the ~urf~ce 12. ~hen the device i~ i~planted, the porous surface 12 and the ~ubsurf~ce network 13 promote cellular ingrowth and the formation of a s~ooth, thin, adherent tis~ue coating, not shovn, on th~ porous surface 12. This coating renders the graft component 11 bioco~patlble and he~oco~patible and specifically ~11OWB the surfDce 12 to remain resistant to the for~ation of blood clot8 ~nd the like normally as~ociated with the presence of foreign bodies, such as grafts or prostbeses~ in the blood stream~ Additionally, the coating facilitates a ~ecore attach~ent of the graft :~ -into ~be cardiovascular ~yste~
The methods by ~hich the graft component 11 may be fabricated include those disclosed i~
Pate~t ~o. ~,~75,972. In one fabrication method disclosed in ~.S. Patent ~o. ~,~75,972, and termed BolUtion processing~, a biocomp2tible polymeric ~ater1al, such ~8 biocompatible polyureth~ne, i8 dissolved in a suitabl~ solvent, such as diDethyl for~a~ide, to form a v:Lscous sQlution. The resultant ~wet~ solution i~ puJped under pressure into a ; didtributor and out tb~ouq~ one or ~ore orifices to for~ one or ~ore continuous fi}a~en~ of tubular :-~ate~i~l. ffl e e~truded fi~er or ibor~ are placed in cont~c~ ~ith ~ rot~ting ~andr~l. Because the eyt~rior d~ai~tes ~iYe of the ~ndr~l ~ill deter~ine the inn~ dl~et~r 31s~ of tbe gra~ ~o~po~ot 11, ~ : .
g~gt o al~o~t a~y l~tarnal dia e~ nay be o~de by choo~lng a ~a~dr&~ of ~h~ approp~l~t4 ~
Th~ trlbutor or spln~r~tt~ reelproc~te~ fro~ O~Q
", ; .
"- Z(~075~Z
axial end of ~he mandrel to the other 90 that the fibers are wound onto the mandrel in different and OppO 8i te direction~.
The conditions of the winding proceP6 are S critical for purposes of opti~i~ing t:hose characteristics which directly affect the p*rformance of the graft component 11. On~ such ~haracteristic i8 the compliance of the graft component 11. This characteristic may be varied by selecting the appropriate diameter of the fiber ~ro~ which the graft oomponent 11 i8 for~ed. The circumferential speed of the rotating mandrel will deter~ine to what degree the fiber extruded in contact with the m,~ndrel will stretch. The greater the stretch, the s~aller the diamete~ of the ~iber and the greater the fle~ibllity and compliance of the resultant graft.
Compliance may also be varied according to the angle at which the f iber used to for~ the graft component ~ ~ .
11 i8 wound. Radial compliance varieR on an inverse proportional basis to the angle of winding, with a les co~pli~nt ~raft made by increasiAg the angle of winding, defined as an acute angle ~ith r~pect to the a~is of the graft or oandrel on which it iA
wound.
~Xink re~i3tance~, that iR, the ability of the graft to be bent without gre~tly reducing the croso-~ectional area of the inside of the gr~ft, i8 anotber chnr~cteristlc which D~y be varied by t~e angle at ~blch the fibær for~ing the gr~t co~ponent 30 11 iff ~ound. ~ graft ~ltb little ~kink re~istanc~
will ~ink with only llttle bending o~ the grat thereby stopping the flo~ o~ blood. Tbe larger the ~nql~ of ~lndi~g~ the gre~te~ the abllity of the gr~t to ~ith~nd fle~ing ~i~bout ~lnki~g, a~d the 35 ~ore u~ful t~ gr~ft 18 for applic~tion i~ losatlons ~hl~h ~y b~ sub~ct~d to ~uch fle~l~g.
~ - ~o :
-9- ~;
The poroQity and the shape of the pore~ of ~
th~ graft dependq al80 on the angle at which the ;:
fiber i8 wound onto the mar~drel. Specifically, a -~
smaller angle of ~inding will produce a ~maller pore 5 size and reduced porosity. The ~pinnerette i~
allowed to reciprocate with re~pect to the ~andrel .,.~.;~;.
until the desired thickne~s of overlayed f ilament~ i8 obtained. When desired, the ~ilaments ~8y be extruded f rom the mandrel ~wet, and upon ev~poration of the solvent, the fila~ent~ Gecurely bond to each other at the point of overlap. A stable and non-woven structure result~ without the need for ~dditlonal proces~$ng.
While spinnable polyurethane materials are -preferred, the graft may al80 be made from other polymeric materials, such as polyolefin~ including polyethylene. With zuch polyl-eric materials, the .:
spinnerette ~ay be heated to produce tacky, fusible, and substantially solven~-free f ibers which bond to ~ :
20 each otber on the mandrel as the fiber~ cool.
Alternatively, the ~andrel ~ay be heated to use :' fibers ~18 they are laid on ~ach other ~
The reinforcing sleeve co~ponent according :
to the present invention 1~ illustrated in Piqure 2 through Figure 6. Thi~ co~ponent includes one or more layers which for~ a sleeve that i~ suitable for ~.
fitting over the graft co~ponent of th~ graft ~ :
asse~bly accord~ng to the invention.
One e~bodi~nt of t~e rei~foro$ng sleeve co~ponent according to the pre~ent inv~ntio~, ~, de~ignated 20 ~n Pig~re 2, include~ three layer~s i flrst or ~t2rna1 l~yer 21~ ~ se~ond or lntes~ed~ate l~yer 31S ~d ~ third cr ~ter~l layer ~ e in1:ern~ y-r 21 any b~ f orDed f ro~ ~y~bet~, 35 blologl~, or bioq?~thetlc and ge~rally bio~o~patl~
~at~ri~ ~<:cord~ng ~o ~h~ ~thod taught in , ~ ........... . .
. .
~ Z~)0756i~
-10- ~
:
Patent No. 4,475,972 (as generally described above) and from fibers 24 which ~ay ~ange f,rom about 1 micron to about 100 ~icrons and preferrably from S to ~ :
30 microns in diameter. ~he resultant internal layer 21 has an inner cylindrical surface ;22 who~e diameter is equal to or greater than the esterior dia~eter of the mandrel, not shown, on which the internal layer 21 i8 formed.
Onto the outer cylindrical sur~ace 23 of the internal layer 21, nn inter~ediate layer 31 may be wound. ~he inter~ediate layer ~ay be for~ed fro~
fibers of a biocompatible material according to the method taught in U.S. P~tent ~o. ~,475,972.
Preerably, the fibers are in the ~hape of a ribbon or f ilament 3~ which i8 generally flat or rect~ngular in cro~s ~ection, thereby enhancing the ~tiffness of the eleeve component 20. The fibers of thi~
intermediate layer 21 could be generally circular, depending upon the particular stiffne 8 propertie~ :
th~t are needed for the 61eeve co~ponent 20. ~he ribbon or fila~ent 3~ ound at an angle r~nging fro~ 35 to 85 w~th re~pect to th~ com~o~
longitudinAl ~ of the reinforced vascular gr~ft 20 and ~ay h~ve a dia~ter ~bicb ~y range i~ si~e fro 300 to 3,000 microns and preferably 500 to 1,000 microns .
An e~ternal layer ~1 ~ay be fabricated and laid over the out2r AUrf -CO 33 0~ tbe inter~ediate laye~ 31 according ~o tbe ~ethod~ disclo~ed in ~.S, 30 Pd~. ~o. ~,~75,972 aad as d~scu3sed ~bove.
Biocoapatible ~aterial in th~ gor~ of f~ber~
~$cron to 100 ~icro~s ~d pref~r~bly 5 to 30 ~icro~
in dia~e~er ~ay bo u~d to ~a~ the e~te~al layer ~:
4~.
, r' )7562 :-~
: ':'' "
--11-- ;,,... .:` .
~.... ...
In order to enh~nce its resi tance to biodegradation, the reinforcing ~leeve component 20 ~:
may ~e given an atraumatic ~hape. With reference to .:
Figures 4 through 6, this m~y be accompli~hed by, for e~a~ple, spinning a plurality of the fiber~ 44 which forD esternal layer 41 and a plurality of the fibers ~
24 vhich form internal layer 21 beyond the end~ 35 of ~.
the ribbon or ~ilament 34 fro~ Yhich intermedi~te layer 31 i~ for~ed, thereby encapsulating or covering ` .
10 the ends of the inter~ediate layer 31 to for~ a : :
surface ~4a. Pibers 2~ and fib~rs 44, which form internal layer 21 ~nd for~ estesnal layer ~
respectively and are spun beyond the ends of the inter~ediate layer 31, ~y be heated, as with the 15 entire co~ponent 20 to form a surface ~4a which is : :
~ooth. Alternatively or additionally, the :
reinforcing slee~e component 20 may be rendered : :
atrau~atic by applying a bead 3~b of a soft poly~er, `~
such as silicone rubber, to the ends of the f ibers , :
20 exposed at the periphery, or by pro~idlng the ~einorcing sleeve co~ponent 20 with a n~nic~red ead 4S sucb a~ by flarinq, tailoring, 801~ent ~anicuring and the like. Generally, ~hen these types of :~ .
treata~nt~ ar~ carried oUt on the reinforcing sleev~ . ;
component 20 they ~re ~08t advantageously c~rried out on tho ~ib~rs 3~ ~hich for~ the inter~ediate poly-eric Eibbon or fila~ent layer 31 Another embodl~ent o~ tbe relnforcing ~leeve co~ponent ~ccording to the pre~nt in~ention 30 include~ a slngle l~y~r designated 50 in ~igu~e 3. .
~he layer 50 -y be fabric~ted by ~ ~uitable ~ethod sucb ~ ~h~t dl~closed ln V.~. Patent ~o. ~75,972 by ~ln~lng fiber~ 34A, au~h ~i~ thoe0 ~ r~ a b~ooo~tlbl~ ~t~rl~l a~ ~bout 1 ~icro~ ~o ~bout 100 ~ oi~J i~ dla ~ter, onto a totatl~ ndrel ~t an a~qi~ ~ltbl~ th~ rai~g~ of about 75 ~ 10~
-2~1 )75~;~
respect to the common longitudinal axis of the mandrel. A generally noncompliant ,and very kink resistant tubular structure result~. ~pon completion of the winding, the reinforcing sle~eve component 31a 5 thus formed may be protected from biodegradation by suitable procedure~ or treatment~. j A further embodiment of the reinforcing sleeve co~p~n~nt according to the present invention :
i~ illustr~ted by the layer 50 in Figure 3. In this embodi~ent, the layer S0 ~ay be fabricat~d by a suitable method such a~ that diwlos~d in ~.S. Patent No. 4,~75,972, from flbe~ 34a which are ~ade from a biocompatible material havinq a relatively high durometer hardne8~ that i8 g~eater than that of the fibers out of which graft component 31 is constructed. For e~ample, graft co~ponent 31 can be made fro~ Pellethane 80A polyurethane fibers, while the fibers 34a ~ould be made of a harder ~terial such as Pellethane 75D or Pelleth~ne 55D polyurethane 20 3~teri~1180 Fiber~ 348 typically range f ro~ about 1 ~icron to ~out 100 Dicrons in dia~eter ~nd are wound onto a ~andrel at an angle ~ithin the range of about 65~20 with reape~t to the longitudinal ~ of the .
25 ~4ndrel. A relatively non-co~pliant, but ve~y .
kink-resi~tant, tubul~r str~cture result~. Upon .
co~pletion o~ the ~inding, the reinforcing ~lee~e .
co~ponent 31a thu~ for~ed ~y be p~otected fro~
biodegr~tlon by ~ult~ble treatments or othe~
., 30 prvcedur~s.
A re~nforced v~scular grDf~ according to the pr~sent invention a~y be for~ed by plncing, such al ~ing, ~ny o~ o~ th~ ~æbod~ents o~ th~
re~nfor~g ~lo ~ ~ ~o~pone~ oY~r th~ gr~t co~ponent 11 to thor~by ~or~ tb~ re~nfo~c~d gra~t a~e3bly.
~h~ ~Y~r~ oDpll~ of th~ rei~orc~ gr~ft Day b~
.
~ 07562 : ~
.: ., :.
controlled, to a certain degree, by the means used to join the two component~, which may be accompli~hed during a surgical procedure. Por e~ample, if graft component 11 i~ held within th~ reir~orcing sleeve co~ponent 20 or 50 by a friction fit:, a relatiYely lesser compliant reinforced graft a~6embly will result. A ~ore compliant rein~orced gra~t as~e~bly will re~ult if the graft coDponent 11 i~ loo~ely hl~ld within the reinforcing slee~e component 20 or 50 80` :~
th~t a spacing ~ay be provided between the two co~ponent~. Spacing would aid in the maintenance of the pulsatile flow through the assembly. The two cooponents of a more co~pliant reinforced graft asse~bly may be fixed through the application of any appropriate fi~ative ~eans, such as adhe~ives, for e~ample, cyDnoacrylate ce~ent, fibrin glue, etc., or mechanical ~eans, for e~n~ple, 8uture8, velcro 8trip8, etc. to one or bo~b ends of the two ~ --coDpon~rlts. ~ ~
Accordingly, th~ co-pliance of the ~;
reinforced graft aase~bly of the pre~ent inv~nt-on i~
ad~ust~ble in variou~ ~ays. One c~n control the angle ot whicb the fibess, th~t for~ eitber or both of tbe co~ponents, e~pecially the sle2ve, are ~ound.
Gener~lly, the gre~ter the ~inding angle wlth respect to the longitudinal a~s of the ~andrel, the le~s co~pliant the graft. One c~n u~e f~b~ra of differing h~rdness. One ¢an use u~ti~le layer~ to forn th~
reinforc~ng ~leeve co~ponent. Co~pli~nce of the rein~orced graft ~ e~bly is ~l~o controlled by select~ng the ~ana used to ~oin th~ t~o co~ponents of the ~sse b1y. ~or e~pl~O u~ing ~ fe~
~t~rrupted xutures ~o ~æcur~ ~he ~8~bly togeth~r ~ould ~lntaln eup*rlor aonpllAnc~. ~ddi~ion~lly, ~q p~71ding ~p~ g betwee~ th~ tvo co~pon~nt~t ~ ~or~
eoapll~nt ~8~Dbly re~ul tB.
.
;~t)0'7~
.
It will be understood that the embodiments of the present invention as described are illustrative of some o~ the applications of the principles of the present invention. Hodifications 5 may be made by those skilled in the art without departure from the spirit and 8COpe of the invention.
~ ~.
,! . ~ . i ~
't , . ..... '" .
!", ,.~ '. ' ., . . , '
, r' )7562 :-~
: ':'' "
--11-- ;,,... .:` .
~.... ...
In order to enh~nce its resi tance to biodegradation, the reinforcing ~leeve component 20 ~:
may ~e given an atraumatic ~hape. With reference to .:
Figures 4 through 6, this m~y be accompli~hed by, for e~a~ple, spinning a plurality of the fiber~ 44 which forD esternal layer 41 and a plurality of the fibers ~
24 vhich form internal layer 21 beyond the end~ 35 of ~.
the ribbon or ~ilament 34 fro~ Yhich intermedi~te layer 31 i~ for~ed, thereby encapsulating or covering ` .
10 the ends of the inter~ediate layer 31 to for~ a : :
surface ~4a. Pibers 2~ and fib~rs 44, which form internal layer 21 ~nd for~ estesnal layer ~
respectively and are spun beyond the ends of the inter~ediate layer 31, ~y be heated, as with the 15 entire co~ponent 20 to form a surface ~4a which is : :
~ooth. Alternatively or additionally, the :
reinforcing slee~e component 20 may be rendered : :
atrau~atic by applying a bead 3~b of a soft poly~er, `~
such as silicone rubber, to the ends of the f ibers , :
20 exposed at the periphery, or by pro~idlng the ~einorcing sleeve co~ponent 20 with a n~nic~red ead 4S sucb a~ by flarinq, tailoring, 801~ent ~anicuring and the like. Generally, ~hen these types of :~ .
treata~nt~ ar~ carried oUt on the reinforcing sleev~ . ;
component 20 they ~re ~08t advantageously c~rried out on tho ~ib~rs 3~ ~hich for~ the inter~ediate poly-eric Eibbon or fila~ent layer 31 Another embodl~ent o~ tbe relnforcing ~leeve co~ponent ~ccording to the pre~nt in~ention 30 include~ a slngle l~y~r designated 50 in ~igu~e 3. .
~he layer 50 -y be fabric~ted by ~ ~uitable ~ethod sucb ~ ~h~t dl~closed ln V.~. Patent ~o. ~75,972 by ~ln~lng fiber~ 34A, au~h ~i~ thoe0 ~ r~ a b~ooo~tlbl~ ~t~rl~l a~ ~bout 1 ~icro~ ~o ~bout 100 ~ oi~J i~ dla ~ter, onto a totatl~ ndrel ~t an a~qi~ ~ltbl~ th~ rai~g~ of about 75 ~ 10~
-2~1 )75~;~
respect to the common longitudinal axis of the mandrel. A generally noncompliant ,and very kink resistant tubular structure result~. ~pon completion of the winding, the reinforcing sle~eve component 31a 5 thus formed may be protected from biodegradation by suitable procedure~ or treatment~. j A further embodiment of the reinforcing sleeve co~p~n~nt according to the present invention :
i~ illustr~ted by the layer 50 in Figure 3. In this embodi~ent, the layer S0 ~ay be fabricat~d by a suitable method such a~ that diwlos~d in ~.S. Patent No. 4,~75,972, from flbe~ 34a which are ~ade from a biocompatible material havinq a relatively high durometer hardne8~ that i8 g~eater than that of the fibers out of which graft component 31 is constructed. For e~ample, graft co~ponent 31 can be made fro~ Pellethane 80A polyurethane fibers, while the fibers 34a ~ould be made of a harder ~terial such as Pellethane 75D or Pelleth~ne 55D polyurethane 20 3~teri~1180 Fiber~ 348 typically range f ro~ about 1 ~icron to ~out 100 Dicrons in dia~eter ~nd are wound onto a ~andrel at an angle ~ithin the range of about 65~20 with reape~t to the longitudinal ~ of the .
25 ~4ndrel. A relatively non-co~pliant, but ve~y .
kink-resi~tant, tubul~r str~cture result~. Upon .
co~pletion o~ the ~inding, the reinforcing ~lee~e .
co~ponent 31a thu~ for~ed ~y be p~otected fro~
biodegr~tlon by ~ult~ble treatments or othe~
., 30 prvcedur~s.
A re~nforced v~scular grDf~ according to the pr~sent invention a~y be for~ed by plncing, such al ~ing, ~ny o~ o~ th~ ~æbod~ents o~ th~
re~nfor~g ~lo ~ ~ ~o~pone~ oY~r th~ gr~t co~ponent 11 to thor~by ~or~ tb~ re~nfo~c~d gra~t a~e3bly.
~h~ ~Y~r~ oDpll~ of th~ rei~orc~ gr~ft Day b~
.
~ 07562 : ~
.: ., :.
controlled, to a certain degree, by the means used to join the two component~, which may be accompli~hed during a surgical procedure. Por e~ample, if graft component 11 i~ held within th~ reir~orcing sleeve co~ponent 20 or 50 by a friction fit:, a relatiYely lesser compliant reinforced graft a~6embly will result. A ~ore compliant rein~orced gra~t as~e~bly will re~ult if the graft coDponent 11 i~ loo~ely hl~ld within the reinforcing slee~e component 20 or 50 80` :~
th~t a spacing ~ay be provided between the two co~ponent~. Spacing would aid in the maintenance of the pulsatile flow through the assembly. The two cooponents of a more co~pliant reinforced graft asse~bly may be fixed through the application of any appropriate fi~ative ~eans, such as adhe~ives, for e~ample, cyDnoacrylate ce~ent, fibrin glue, etc., or mechanical ~eans, for e~n~ple, 8uture8, velcro 8trip8, etc. to one or bo~b ends of the two ~ --coDpon~rlts. ~ ~
Accordingly, th~ co-pliance of the ~;
reinforced graft aase~bly of the pre~ent inv~nt-on i~
ad~ust~ble in variou~ ~ays. One c~n control the angle ot whicb the fibess, th~t for~ eitber or both of tbe co~ponents, e~pecially the sle2ve, are ~ound.
Gener~lly, the gre~ter the ~inding angle wlth respect to the longitudinal a~s of the ~andrel, the le~s co~pliant the graft. One c~n u~e f~b~ra of differing h~rdness. One ¢an use u~ti~le layer~ to forn th~
reinforc~ng ~leeve co~ponent. Co~pli~nce of the rein~orced graft ~ e~bly is ~l~o controlled by select~ng the ~ana used to ~oin th~ t~o co~ponents of the ~sse b1y. ~or e~pl~O u~ing ~ fe~
~t~rrupted xutures ~o ~æcur~ ~he ~8~bly togeth~r ~ould ~lntaln eup*rlor aonpllAnc~. ~ddi~ion~lly, ~q p~71ding ~p~ g betwee~ th~ tvo co~pon~nt~t ~ ~or~
eoapll~nt ~8~Dbly re~ul tB.
.
;~t)0'7~
.
It will be understood that the embodiments of the present invention as described are illustrative of some o~ the applications of the principles of the present invention. Hodifications 5 may be made by those skilled in the art without departure from the spirit and 8COpe of the invention.
~ ~.
,! . ~ . i ~
't , . ..... '" .
!", ,.~ '. ' ., . . , '
Claims (27)
1. A reinforced graft assembly, comprising:
(a) a compliant graft component, which is an elongated generally compliant blood transporting cylindrical synthetic, biologic or biosynthetic vascular graft having an outer diameter; and (b) a sleeve component, said sleeve component being a reinforcing sleeve capable of being fixed over said graft component, said sleeve including non-interwoven fibers made from a biocompatible material, said sleeve component having an interior surface with a diameter equal to or larger than said outer diameter of said graft component, whereby said sleeve component provides the primary load bearing function of the reinforced graft assembly, and said compliant graft component is isolated from said sleeve component and provides the blood transporting function of the reinforced graft assembly.
(a) a compliant graft component, which is an elongated generally compliant blood transporting cylindrical synthetic, biologic or biosynthetic vascular graft having an outer diameter; and (b) a sleeve component, said sleeve component being a reinforcing sleeve capable of being fixed over said graft component, said sleeve including non-interwoven fibers made from a biocompatible material, said sleeve component having an interior surface with a diameter equal to or larger than said outer diameter of said graft component, whereby said sleeve component provides the primary load bearing function of the reinforced graft assembly, and said compliant graft component is isolated from said sleeve component and provides the blood transporting function of the reinforced graft assembly.
2. The reinforced graft assembly according to claim 1, wherein said fibers of said sleeve component have a diameter of between about 1 micron and about 100 microns.
3. The reinforced graft assembly according to claim 2, wherein said fibers of said sleeve component are wound onto a mandrel at an angle in the range of 65° to 85° to a longitudinal axis of said mandrel.
4. The reinforced graft assembly according to claim 2, wherein said fibers of said sleeve component are wound onto a mandrel at an angle in the range of 45° to 85° to a longitudinal axis of said mandrel.
5. The reinforced graft assembly according to claim 4, wherein said biocompatible material has a durometer reading greater than that of Pellethane 80A
polyurethane.
polyurethane.
6. The reinforced graft assembly according to claim 3, wherein said sleeve component is fixed over said compliant graft component by means of adhesives.
7. The reinforced graft assembly according to claim 3, wherein said sleeve component is fixed over said compliant graft component by means of sutures.
8. The reinforced graft assembly according to claim 5, wherein said sleeve component is fixed over said compliant graft component by means of adhesives.
9. The reinforced graft assembly according to claim 5, wherein said sleeve component is fixed over said compliant graft component by means of sutures.
10. A reinforced graft assembly, comprising:
(a) a compliant graft component, said graft component having an inner surface and an outer surface, said graft component being made from synthethic, biologic, or biosynthetic materials;
and (b) a sleeve component, said sleeve component being made from synthetic, biologic, or biosynthetic materials, said sleeve component having an inner diameter suitably sized so the sleeve component may be fitted over the graft component, whereby said sleeve component provides complaint reinforcement to said graft component.
(a) a compliant graft component, said graft component having an inner surface and an outer surface, said graft component being made from synthethic, biologic, or biosynthetic materials;
and (b) a sleeve component, said sleeve component being made from synthetic, biologic, or biosynthetic materials, said sleeve component having an inner diameter suitably sized so the sleeve component may be fitted over the graft component, whereby said sleeve component provides complaint reinforcement to said graft component.
11. The reinforced graft assembly according to claim 10, wherein said sleeve component includes one or more layers which individually or as a group provide said reinforcement to said graft component.
12. The reinforced graft assembly according to claim 11, wherein said one or more layers includes an internal layer, an intermediate layer, and an external layer.
13. The reinforced graft assembly according to claim 12, wherein said internal layer includes fibers having a diameter in the range of 1 micron to 100 microns.
14. The reinforced graft assembly according to claim 12, wherein said intermediate layer includes fibers in the form of a ribbon or filament having a diameter in the range of 300 to 3,000 microns.
15. The reinforced graft assembly according to claim 12, wherein said external layer includes fibers having a diameter in the range of 1 micron to 10 microns.
16. The reinforced graft assembly according to claim 12, wherein said internal layer, intermediate layer, and external layer include fibers wound consecutively over a mandrel.
17. The reinforced graft assembly according to claim 16, wherein said intermediate layer is wound at an angle in the range of 35° to 85° to a longitudinal axis of said mandrel.
18. The reinforced graft assembly according to claim 13, wherein said fibers of said internal layer are made from polymeric material integrally bonded together.
19. The reinforced graft assembly according to claim 14, wherein said ribbon or filament of said intermediate layer is made from polymeric material integrally bonded together.
20. The reinforced graft assembly according to claim 15, wherein said fibers of said external layer are polymeric fibers which are integrally bonded together.
21. The reinforced graft assembly according to claim 12, wherein said intermediate layer includes a plurality of fibers spun longitudinally outward from edges of said intermediate layer to aid in protection of said intermediate layer from biodegradation.
22. The reinforced graft assembly according to claim 12, wherein said intermediate layer includes a soft polymer applied to ends of the fibers of said intermediate layer to aid in protection of said assembly from biodegradation.
23. The reinforced graft assembly according to claim 12, wherein said sleeve component includes manicured ends to aid in protection of said assembly from biodegradation.
24. A reinforced graft assembly particularly for cardiovascular use, said assembly comprising:
(a) a reinforcing component, said reinforcing component having a tubular structure of one or more layers of non-interwoven fibers of biocompatible material, said reinforcing component being capable of bearing a load imparted by or onto said assembly; and (b) a graft component, said graft component having a tubular structure made from synthetic, biologic, or biosynthetic materials, said graft component being suitable for transporting blood, said graft component sized so said reinforcing component may be fitted over said graft component to form said reinforced graft assembly.
(a) a reinforcing component, said reinforcing component having a tubular structure of one or more layers of non-interwoven fibers of biocompatible material, said reinforcing component being capable of bearing a load imparted by or onto said assembly; and (b) a graft component, said graft component having a tubular structure made from synthetic, biologic, or biosynthetic materials, said graft component being suitable for transporting blood, said graft component sized so said reinforcing component may be fitted over said graft component to form said reinforced graft assembly.
25. A method of forming a compliant and reinforced graft assembly, which method comprises providing a reinforced sleeve component by a procedure including:
(a) winding extruded fibers made from biocompatible material onto a mandrel to form an internal layer of a reinforcing sleeve component;
(b) winding extruded fibers made from said biocompatible material and drawn in the shape of a ribbon or filament onto said internal layer to form an intermediate layer of said reinforcing sleeve component; and (c) winding extruded fibers made from said biocompatible material onto said intermediate layer to form an external layer of said reinforcing sleeve component; and (d) sliding aid reinforcing sleeve component thus formed over a compliant graft to provide said compliant and reinforced graft assembly.
(a) winding extruded fibers made from biocompatible material onto a mandrel to form an internal layer of a reinforcing sleeve component;
(b) winding extruded fibers made from said biocompatible material and drawn in the shape of a ribbon or filament onto said internal layer to form an intermediate layer of said reinforcing sleeve component; and (c) winding extruded fibers made from said biocompatible material onto said intermediate layer to form an external layer of said reinforcing sleeve component; and (d) sliding aid reinforcing sleeve component thus formed over a compliant graft to provide said compliant and reinforced graft assembly.
26. A method of forming a compliant and reinforced graft assembly, which method comprises:
forming a reinforcing sleeve component by winding fibers made from biocompatible material into a tubular shape said winding being without weaving the fibers together; and sliding said reinforcing sleeve component thus formed over a compliant graft to form said compliant and reinforced graft assembly in which the compliance of said co pliant graft is substantially maintained.
forming a reinforcing sleeve component by winding fibers made from biocompatible material into a tubular shape said winding being without weaving the fibers together; and sliding said reinforcing sleeve component thus formed over a compliant graft to form said compliant and reinforced graft assembly in which the compliance of said co pliant graft is substantially maintained.
27. The method according to claim 26, wherein said reinforcing sleeve component is further treated by imparting an atraumatic shape to longitudinal ends of said fibers thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/377,463 US5084065A (en) | 1989-07-10 | 1989-07-10 | Reinforced graft assembly |
US377,463 | 1989-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2007562A1 true CA2007562A1 (en) | 1991-01-10 |
Family
ID=23489208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002007562A Abandoned CA2007562A1 (en) | 1989-07-10 | 1990-01-11 | Reinforced graft assembly |
Country Status (4)
Country | Link |
---|---|
US (1) | US5084065A (en) |
EP (1) | EP0407692A1 (en) |
JP (1) | JP2739878B2 (en) |
CA (1) | CA2007562A1 (en) |
Families Citing this family (327)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5275622A (en) * | 1983-12-09 | 1994-01-04 | Harrison Medical Technologies, Inc. | Endovascular grafting apparatus, system and method and devices for use therewith |
US5104399A (en) | 1986-12-10 | 1992-04-14 | Endovascular Technologies, Inc. | Artificial graft and implantation method |
US7166125B1 (en) | 1988-03-09 | 2007-01-23 | Endovascular Technologies, Inc. | Intraluminal grafting system |
US20040127969A1 (en) * | 1987-04-06 | 2004-07-01 | Lazarus Harrison M. | Artificial graft and implantation method |
US5133732A (en) * | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US6171338B1 (en) * | 1988-11-10 | 2001-01-09 | Biocon, Oy | Biodegradable surgical implants and devices |
US5178634A (en) * | 1989-03-31 | 1993-01-12 | Wilson Ramos Martinez | Aortic valved tubes for human implants |
US6344053B1 (en) | 1993-12-22 | 2002-02-05 | Medtronic Ave, Inc. | Endovascular support device and method |
US5242399A (en) * | 1990-04-25 | 1993-09-07 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
US5344426A (en) * | 1990-04-25 | 1994-09-06 | Advanced Cardiovascular Systems, Inc. | Method and system for stent delivery |
EP0576517B1 (en) * | 1991-03-25 | 1997-05-07 | Meadox Medicals Inc. | Vascular prosthesis |
US5383925A (en) * | 1992-09-14 | 1995-01-24 | Meadox Medicals, Inc. | Three-dimensional braided soft tissue prosthesis |
US5662713A (en) * | 1991-10-09 | 1997-09-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
CA2380683C (en) * | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5258042A (en) * | 1991-12-16 | 1993-11-02 | Henry Ford Health System | Intravascular hydrogel implant |
US5562725A (en) | 1992-09-14 | 1996-10-08 | Meadox Medicals Inc. | Radially self-expanding implantable intraluminal device |
US5628782A (en) * | 1992-12-11 | 1997-05-13 | W. L. Gore & Associates, Inc. | Method of making a prosthetic vascular graft |
US5716395A (en) * | 1992-12-11 | 1998-02-10 | W.L. Gore & Associates, Inc. | Prosthetic vascular graft |
US5443458A (en) * | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
WO1994021196A2 (en) * | 1993-03-18 | 1994-09-29 | C.R. Bard, Inc. | Endovascular stents |
US5441515A (en) * | 1993-04-23 | 1995-08-15 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
US5913894A (en) * | 1994-12-05 | 1999-06-22 | Meadox Medicals, Inc. | Solid woven tubular prosthesis |
US5456667A (en) * | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
US5527353A (en) * | 1993-12-02 | 1996-06-18 | Meadox Medicals, Inc. | Implantable tubular prosthesis |
JP2703510B2 (en) * | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
US6051020A (en) * | 1994-02-09 | 2000-04-18 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
US6039749A (en) | 1994-02-10 | 2000-03-21 | Endovascular Systems, Inc. | Method and apparatus for deploying non-circular stents and graftstent complexes |
US6334872B1 (en) | 1994-02-18 | 2002-01-01 | Organogenesis Inc. | Method for treating diseased or damaged organs |
US5556413A (en) * | 1994-03-11 | 1996-09-17 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5584876A (en) * | 1994-04-29 | 1996-12-17 | W. L. Gore & Associates, Inc. | Cell excluding sheath for vascular grafts |
WO1995029646A1 (en) * | 1994-04-29 | 1995-11-09 | Boston Scientific Corporation | Medical prosthetic stent and method of manufacture |
US5476508A (en) * | 1994-05-26 | 1995-12-19 | Tfx Medical | Stent with mutually interlocking filaments |
EP0792627B2 (en) | 1994-06-08 | 2003-10-29 | Cardiovascular Concepts, Inc. | System for forming a bifurcated graft |
US5629077A (en) * | 1994-06-27 | 1997-05-13 | Advanced Cardiovascular Systems, Inc. | Biodegradable mesh and film stent |
US5527355A (en) * | 1994-09-02 | 1996-06-18 | Ahn; Sam S. | Apparatus and method for performing aneurysm repair |
US5843170A (en) * | 1994-09-02 | 1998-12-01 | Ahn; Sam Seunghae | Apparatus and method for performing aneurysm repair |
US5707378A (en) * | 1994-09-02 | 1998-01-13 | Sam S. Ahn | Apparatus and method for performing aneurysm repair |
US5649977A (en) * | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
US5707385A (en) * | 1994-11-16 | 1998-01-13 | Advanced Cardiovascular Systems, Inc. | Drug loaded elastic membrane and method for delivery |
US5637113A (en) * | 1994-12-13 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | Polymer film for wrapping a stent structure |
US5741332A (en) * | 1995-01-23 | 1998-04-21 | Meadox Medicals, Inc. | Three-dimensional braided soft tissue prosthesis |
US5683449A (en) * | 1995-02-24 | 1997-11-04 | Marcade; Jean Paul | Modular bifurcated intraluminal grafts and methods for delivering and assembling same |
US6264684B1 (en) | 1995-03-10 | 2001-07-24 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Helically supported graft |
US6451047B2 (en) | 1995-03-10 | 2002-09-17 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
US6039755A (en) * | 1997-02-05 | 2000-03-21 | Impra, Inc., A Division Of C.R. Bard, Inc. | Radially expandable tubular polytetrafluoroethylene grafts and method of making same |
US6053943A (en) * | 1995-12-08 | 2000-04-25 | Impra, Inc. | Endoluminal graft with integral structural support and method for making same |
US6124523A (en) * | 1995-03-10 | 2000-09-26 | Impra, Inc. | Encapsulated stent |
EP0814729B1 (en) * | 1995-03-10 | 2000-08-09 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture |
US5605696A (en) * | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
US20020095218A1 (en) | 1996-03-12 | 2002-07-18 | Carr Robert M. | Tissue repair fabric |
US6143007A (en) * | 1995-04-28 | 2000-11-07 | Target Therapeutics, Inc. | Method for making an occlusive device |
US5667523A (en) * | 1995-04-28 | 1997-09-16 | Impra, Inc. | Dual supported intraluminal graft |
EP0830110B2 (en) * | 1995-06-07 | 2010-08-04 | Edwards Lifesciences Corporation | Externally supported tape reinforced vascular graft |
US6814748B1 (en) | 1995-06-07 | 2004-11-09 | Endovascular Technologies, Inc. | Intraluminal grafting system |
US5782907A (en) * | 1995-07-13 | 1998-07-21 | Devices For Vascular Intervention, Inc. | Involuted spring stent and graft assembly and method of use |
EP0850030B1 (en) | 1995-08-24 | 2004-07-21 | Bard Peripheral Vascular, Inc. | Method of assembly of a covered endoluminal stent |
US5843158A (en) * | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
DE69732794T2 (en) | 1996-01-05 | 2006-04-06 | Medtronic, Inc., Minneapolis | EXPANDABLE ENDOLUMINARY PROSTHESIS |
US5769884A (en) * | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
EP0934035B8 (en) | 1996-09-26 | 2006-01-18 | Boston Scientific Scimed, Inc. | Support structure/membrane composite medical device |
US5824047A (en) * | 1996-10-11 | 1998-10-20 | C. R. Bard, Inc. | Vascular graft fabric |
US5976178A (en) * | 1996-11-07 | 1999-11-02 | Vascular Science Inc. | Medical grafting methods |
US5941908A (en) * | 1997-04-23 | 1999-08-24 | Vascular Science, Inc. | Artificial medical graft with a releasable retainer |
US6036702A (en) * | 1997-04-23 | 2000-03-14 | Vascular Science Inc. | Medical grafting connectors and fasteners |
US5957974A (en) * | 1997-01-23 | 1999-09-28 | Schneider (Usa) Inc | Stent graft with braided polymeric sleeve |
US6203735B1 (en) | 1997-02-03 | 2001-03-20 | Impra, Inc. | Method of making expanded polytetrafluoroethylene products |
ATE287679T1 (en) * | 1997-03-05 | 2005-02-15 | Boston Scient Ltd | COMPLIANT MULTI-LAYER STENT DEVICE |
US6240616B1 (en) * | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US8172897B2 (en) * | 1997-04-15 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Polymer and metal composite implantable medical devices |
US10028851B2 (en) * | 1997-04-15 | 2018-07-24 | Advanced Cardiovascular Systems, Inc. | Coatings for controlling erosion of a substrate of an implantable medical device |
US6019777A (en) * | 1997-04-21 | 2000-02-01 | Advanced Cardiovascular Systems, Inc. | Catheter and method for a stent delivery system |
US6776792B1 (en) * | 1997-04-24 | 2004-08-17 | Advanced Cardiovascular Systems Inc. | Coated endovascular stent |
US6033433A (en) | 1997-04-25 | 2000-03-07 | Scimed Life Systems, Inc. | Stent configurations including spirals |
US5906641A (en) * | 1997-05-27 | 1999-05-25 | Schneider (Usa) Inc | Bifurcated stent graft |
CA2235911C (en) * | 1997-05-27 | 2003-07-29 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
US6056993A (en) * | 1997-05-30 | 2000-05-02 | Schneider (Usa) Inc. | Porous protheses and methods for making the same wherein the protheses are formed by spraying water soluble and water insoluble fibers onto a rotating mandrel |
CA2241558A1 (en) | 1997-06-24 | 1998-12-24 | Advanced Cardiovascular Systems, Inc. | Stent with reinforced struts and bimodal deployment |
US6070589A (en) | 1997-08-01 | 2000-06-06 | Teramed, Inc. | Methods for deploying bypass graft stents |
US7753950B2 (en) * | 1997-08-13 | 2010-07-13 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6165195A (en) * | 1997-08-13 | 2000-12-26 | Advanced Cardiovascylar Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6371982B2 (en) | 1997-10-09 | 2002-04-16 | St. Jude Medical Cardiovascular Group, Inc. | Graft structures with compliance gradients |
US5931865A (en) * | 1997-11-24 | 1999-08-03 | Gore Enterprise Holdings, Inc. | Multiple-layered leak resistant tube |
US6048362A (en) * | 1998-01-12 | 2000-04-11 | St. Jude Medical Cardiovascular Group, Inc. | Fluoroscopically-visible flexible graft structures |
US6102918A (en) * | 1998-02-18 | 2000-08-15 | Montefiore Hospital And Medical Center | Collapsible low-profile vascular graft implantation instrument and method for use thereof |
US6235054B1 (en) | 1998-02-27 | 2001-05-22 | St. Jude Medical Cardiovascular Group, Inc. | Grafts with suture connectors |
US6290731B1 (en) | 1998-03-30 | 2001-09-18 | Cordis Corporation | Aortic graft having a precursor gasket for repairing an abdominal aortic aneurysm |
US6656215B1 (en) | 2000-11-16 | 2003-12-02 | Cordis Corporation | Stent graft having an improved means for attaching a stent to a graft |
US6887268B2 (en) | 1998-03-30 | 2005-05-03 | Cordis Corporation | Extension prosthesis for an arterial repair |
MXPA00012062A (en) * | 1998-06-05 | 2003-04-22 | Organogenesis Inc | Bioengineered flat sheet graft prostheses. |
EP1083843A4 (en) * | 1998-06-05 | 2005-06-08 | Organogenesis Inc | Bioengineered vascular graft support prostheses |
ATE424147T1 (en) * | 1998-06-05 | 2009-03-15 | Organogenesis Inc | BIOTECHNICALLY CREATED VASCULAR PROSTHESIS FOR IMPLANTATION |
ATE423577T1 (en) * | 1998-06-05 | 2009-03-15 | Organogenesis Inc | BIOLOGICALLY MODELED IMPLANTABLE PROSTHESES |
US6171334B1 (en) | 1998-06-17 | 2001-01-09 | Advanced Cardiovascular Systems, Inc. | Expandable stent and method of use |
US6461380B1 (en) | 1998-07-28 | 2002-10-08 | Advanced Cardiovascular Systems, Inc. | Stent configuration |
US6159239A (en) * | 1998-08-14 | 2000-12-12 | Prodesco, Inc. | Woven stent/graft structure |
US6156064A (en) * | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
US6117104A (en) * | 1998-09-08 | 2000-09-12 | Advanced Cardiovascular Systems, Inc. | Stent deployment system and method of use |
US6475222B1 (en) * | 1998-11-06 | 2002-11-05 | St. Jude Medical Atg, Inc. | Minimally invasive revascularization apparatus and methods |
US6508252B1 (en) * | 1998-11-06 | 2003-01-21 | St. Jude Medical Atg, Inc. | Medical grafting methods and apparatus |
US6398803B1 (en) * | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
WO2000053104A1 (en) | 1999-03-09 | 2000-09-14 | St. Jude Medical Cardiovascular Group, Inc. | Medical grafting methods and apparatus |
US6620192B1 (en) * | 1999-03-16 | 2003-09-16 | Advanced Cardiovascular Systems, Inc. | Multilayer stent |
US6464723B1 (en) | 1999-04-22 | 2002-10-15 | Advanced Cardiovascular Systems, Inc. | Radiopaque stents |
US6699256B1 (en) | 1999-06-04 | 2004-03-02 | St. Jude Medical Atg, Inc. | Medical grafting apparatus and methods |
US6540774B1 (en) | 1999-08-31 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Stent design with end rings having enhanced strength and radiopacity |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6585757B1 (en) | 1999-09-15 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Endovascular stent with radiopaque spine |
US6334868B1 (en) | 1999-10-08 | 2002-01-01 | Advanced Cardiovascular Systems, Inc. | Stent cover |
US6325823B1 (en) | 1999-10-29 | 2001-12-04 | Revasc Corporation | Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use |
US6475235B1 (en) | 1999-11-16 | 2002-11-05 | Iowa-India Investments Company, Limited | Encapsulated stent preform |
US6251136B1 (en) | 1999-12-08 | 2001-06-26 | Advanced Cardiovascular Systems, Inc. | Method of layering a three-coated stent using pharmacological and polymeric agents |
US6508832B1 (en) | 1999-12-09 | 2003-01-21 | Advanced Cardiovascular Systems, Inc. | Implantable nickel-free stainless steel stents and method of making the same |
US6702849B1 (en) | 1999-12-13 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers |
US6537311B1 (en) | 1999-12-30 | 2003-03-25 | Advanced Cardiovascular Systems, Inc. | Stent designs for use in peripheral vessels |
US6471721B1 (en) | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
US6355058B1 (en) | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
US6296661B1 (en) | 2000-02-01 | 2001-10-02 | Luis A. Davila | Self-expanding stent-graft |
US6245100B1 (en) | 2000-02-01 | 2001-06-12 | Cordis Corporation | Method for making a self-expanding stent-graft |
US6436132B1 (en) | 2000-03-30 | 2002-08-20 | Advanced Cardiovascular Systems, Inc. | Composite intraluminal prostheses |
US8109994B2 (en) * | 2003-01-10 | 2012-02-07 | Abbott Cardiovascular Systems, Inc. | Biodegradable drug delivery material for stent |
US6527801B1 (en) | 2000-04-13 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Biodegradable drug delivery material for stent |
US7875283B2 (en) * | 2000-04-13 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Biodegradable polymers for use with implantable medical devices |
US8845713B2 (en) | 2000-05-12 | 2014-09-30 | Advanced Bio Prosthetic Surfaces, Ltd., A Wholly Owned Subsidiary Of Palmaz Scientific, Inc. | Self-supporting laminated films, structural materials and medical devices manufactured therefrom and methods of making same |
US6652579B1 (en) | 2000-06-22 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent |
US6821295B1 (en) | 2000-06-26 | 2004-11-23 | Thoratec Corporation | Flared coronary artery bypass grafts |
US6986786B1 (en) * | 2000-09-11 | 2006-01-17 | Scimed Life Systerms, Inc. | Endovascular prostethic devices having hook and loop structures |
EP1320390A2 (en) * | 2000-09-18 | 2003-06-25 | Organogenesis Inc. | Bioengineered flat sheet graft prosthesis and its use |
US6652574B1 (en) | 2000-09-28 | 2003-11-25 | Vascular Concepts Holdings Limited | Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer |
US6783793B1 (en) * | 2000-10-26 | 2004-08-31 | Advanced Cardiovascular Systems, Inc. | Selective coating of medical devices |
US7314483B2 (en) * | 2000-11-16 | 2008-01-01 | Cordis Corp. | Stent graft with branch leg |
US7229472B2 (en) | 2000-11-16 | 2007-06-12 | Cordis Corporation | Thoracic aneurysm repair prosthesis and system |
US6843802B1 (en) | 2000-11-16 | 2005-01-18 | Cordis Corporation | Delivery apparatus for a self expanding retractable stent |
US7267685B2 (en) | 2000-11-16 | 2007-09-11 | Cordis Corporation | Bilateral extension prosthesis and method of delivery |
US6942692B2 (en) | 2000-11-16 | 2005-09-13 | Cordis Corporation | Supra-renal prosthesis and renal artery bypass |
US20020084178A1 (en) * | 2000-12-19 | 2002-07-04 | Nicast Corporation Ltd. | Method and apparatus for manufacturing polymer fiber shells via electrospinning |
US20070031607A1 (en) * | 2000-12-19 | 2007-02-08 | Alexander Dubson | Method and apparatus for coating medical implants |
US7244272B2 (en) | 2000-12-19 | 2007-07-17 | Nicast Ltd. | Vascular prosthesis and method for production thereof |
US6641607B1 (en) | 2000-12-29 | 2003-11-04 | Advanced Cardiovascular Systems, Inc. | Double tube stent |
US6635082B1 (en) | 2000-12-29 | 2003-10-21 | Advanced Cardiovascular Systems Inc. | Radiopaque stent |
JP2004530054A (en) * | 2001-03-20 | 2004-09-30 | ナイキャスト リミテッド | Method and apparatus for improving the mechanical properties of nonwoven materials |
US7201940B1 (en) | 2001-06-12 | 2007-04-10 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for thermal spray processing of medical devices |
US6565659B1 (en) * | 2001-06-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Stent mounting assembly and a method of using the same to coat a stent |
US7682669B1 (en) * | 2001-07-30 | 2010-03-23 | Advanced Cardiovascular Systems, Inc. | Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device |
US20040137066A1 (en) * | 2001-11-26 | 2004-07-15 | Swaminathan Jayaraman | Rationally designed therapeutic intravascular implant coating |
US7989018B2 (en) * | 2001-09-17 | 2011-08-02 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US7285304B1 (en) | 2003-06-25 | 2007-10-23 | Advanced Cardiovascular Systems, Inc. | Fluid treatment of a polymeric coating on an implantable medical device |
US6863683B2 (en) | 2001-09-19 | 2005-03-08 | Abbott Laboratoris Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
US7326237B2 (en) * | 2002-01-08 | 2008-02-05 | Cordis Corporation | Supra-renal anchoring prosthesis |
US20030187498A1 (en) * | 2002-03-28 | 2003-10-02 | Medtronic Ave, Inc. | Chamfered stent strut and method of making same |
RU2207825C1 (en) * | 2002-04-04 | 2003-07-10 | Дьяков Валерий Евгеньевич | Full-sclae implantable prosthesis |
US20030236457A1 (en) * | 2002-04-24 | 2003-12-25 | Mericle Robert A. | Method of endovascular brain mapping |
DE10219014A1 (en) * | 2002-04-27 | 2003-11-13 | Ruesch Willy Gmbh | Self-expanding stent for reinforcing and/or keeping open a hollow organ comprise two elastic tubular layers which bracket and positionally fix at least one helical filament |
US7270675B2 (en) * | 2002-05-10 | 2007-09-18 | Cordis Corporation | Method of forming a tubular membrane on a structural frame |
US7485141B2 (en) * | 2002-05-10 | 2009-02-03 | Cordis Corporation | Method of placing a tubular membrane on a structural frame |
US20060271168A1 (en) * | 2002-10-30 | 2006-11-30 | Klaus Kleine | Degradable medical device |
US7144422B1 (en) * | 2002-11-13 | 2006-12-05 | Advanced Cardiovascular Systems, Inc. | Drug-eluting stent and methods of making the same |
US7435255B1 (en) | 2002-11-13 | 2008-10-14 | Advnaced Cardiovascular Systems, Inc. | Drug-eluting stent and methods of making |
FR2847150B1 (en) * | 2002-11-15 | 2005-01-21 | Claude Mialhe | OCCLUSIVE DEVICE WITH MEDICAL OR SURGICAL DESTINATION |
US7758881B2 (en) * | 2004-06-30 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US8435550B2 (en) * | 2002-12-16 | 2013-05-07 | Abbot Cardiovascular Systems Inc. | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device |
US6899729B1 (en) | 2002-12-18 | 2005-05-31 | Advanced Cardiovascular Systems, Inc. | Stent for treating vulnerable plaque |
US7105018B1 (en) | 2002-12-30 | 2006-09-12 | Advanced Cardiovascular Systems, Inc. | Drug-eluting stent cover and method of use |
US7316710B1 (en) | 2002-12-30 | 2008-01-08 | Advanced Cardiovascular Systems, Inc. | Flexible stent |
US6896697B1 (en) | 2002-12-30 | 2005-05-24 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
WO2004100772A2 (en) * | 2003-05-12 | 2004-11-25 | University Of Florida | Devices and methods for disruption and removal of luninal occlusions |
US7186789B2 (en) * | 2003-06-11 | 2007-03-06 | Advanced Cardiovascular Systems, Inc. | Bioabsorbable, biobeneficial polyester polymers for use in drug eluting stent coatings |
WO2005025456A1 (en) * | 2003-09-02 | 2005-03-24 | University Of Florida | Polymeric reconstrainable, repositionable, detachable, percutaneous endovascular stentgraft |
US20050060020A1 (en) * | 2003-09-17 | 2005-03-17 | Scimed Life Systems, Inc. | Covered stent with biologically active material |
US7198675B2 (en) * | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
US20060263474A1 (en) * | 2005-05-23 | 2006-11-23 | Cadbury Adams Usa Llc. | Enhanced flavor-release comestible compositions and methods for same |
US7258697B1 (en) | 2003-12-22 | 2007-08-21 | Advanced Cardiovascular Systems, Inc. | Stent with anchors to prevent vulnerable plaque rupture during deployment |
WO2005065578A2 (en) * | 2004-01-06 | 2005-07-21 | Nicast Ltd. | Vascular prosthesis with anastomotic member |
US20050214339A1 (en) * | 2004-03-29 | 2005-09-29 | Yiwen Tang | Biologically degradable compositions for medical applications |
US20050288481A1 (en) * | 2004-04-30 | 2005-12-29 | Desnoyer Jessica R | Design of poly(ester amides) for the control of agent-release from polymeric compositions |
EP1746952A1 (en) * | 2004-05-20 | 2007-01-31 | Cook Incorporated | Endoluminal device with extracellular matrix material and methods |
US9561309B2 (en) | 2004-05-27 | 2017-02-07 | Advanced Cardiovascular Systems, Inc. | Antifouling heparin coatings |
US8568469B1 (en) | 2004-06-28 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Stent locking element and a method of securing a stent on a delivery system |
US8241554B1 (en) | 2004-06-29 | 2012-08-14 | Advanced Cardiovascular Systems, Inc. | Method of forming a stent pattern on a tube |
US20060020330A1 (en) * | 2004-07-26 | 2006-01-26 | Bin Huang | Method of fabricating an implantable medical device with biaxially oriented polymers |
US7731890B2 (en) * | 2006-06-15 | 2010-06-08 | Advanced Cardiovascular Systems, Inc. | Methods of fabricating stents with enhanced fracture toughness |
US8778256B1 (en) | 2004-09-30 | 2014-07-15 | Advanced Cardiovascular Systems, Inc. | Deformation of a polymer tube in the fabrication of a medical article |
US8747878B2 (en) | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device by controlling crystalline structure |
US8747879B2 (en) * | 2006-04-28 | 2014-06-10 | Advanced Cardiovascular Systems, Inc. | Method of fabricating an implantable medical device to reduce chance of late inflammatory response |
US7971333B2 (en) * | 2006-05-30 | 2011-07-05 | Advanced Cardiovascular Systems, Inc. | Manufacturing process for polymetric stents |
US20060041102A1 (en) * | 2004-08-23 | 2006-02-23 | Advanced Cardiovascular Systems, Inc. | Implantable devices comprising biologically absorbable polymers having constant rate of degradation and methods for fabricating the same |
US9283099B2 (en) * | 2004-08-25 | 2016-03-15 | Advanced Cardiovascular Systems, Inc. | Stent-catheter assembly with a releasable connection for stent retention |
US7229471B2 (en) * | 2004-09-10 | 2007-06-12 | Advanced Cardiovascular Systems, Inc. | Compositions containing fast-leaching plasticizers for improved performance of medical devices |
US7875233B2 (en) | 2004-09-30 | 2011-01-25 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a biaxially oriented implantable medical device |
US8043553B1 (en) | 2004-09-30 | 2011-10-25 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article |
US8173062B1 (en) | 2004-09-30 | 2012-05-08 | Advanced Cardiovascular Systems, Inc. | Controlled deformation of a polymer tube in fabricating a medical article |
US8029563B2 (en) | 2004-11-29 | 2011-10-04 | Gore Enterprise Holdings, Inc. | Implantable devices with reduced needle puncture site leakage |
US7632307B2 (en) * | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
US9545300B2 (en) * | 2004-12-22 | 2017-01-17 | W. L. Gore & Associates, Inc. | Filament-wound implantable devices |
US20100331947A1 (en) * | 2005-02-17 | 2010-12-30 | Alon Shalev | Inflatable Medical Device |
US20060216431A1 (en) * | 2005-03-28 | 2006-09-28 | Kerrigan Cameron K | Electrostatic abluminal coating of a stent crimped on a balloon catheter |
US20060224226A1 (en) * | 2005-03-31 | 2006-10-05 | Bin Huang | In-vivo radial orientation of a polymeric implantable medical device |
US7381048B2 (en) * | 2005-04-12 | 2008-06-03 | Advanced Cardiovascular Systems, Inc. | Stents with profiles for gripping a balloon catheter and molds for fabricating stents |
US7763198B2 (en) * | 2005-04-12 | 2010-07-27 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
US7947207B2 (en) * | 2005-04-12 | 2011-05-24 | Abbott Cardiovascular Systems Inc. | Method for retaining a vascular stent on a catheter |
US7291166B2 (en) * | 2005-05-18 | 2007-11-06 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US7622070B2 (en) * | 2005-06-20 | 2009-11-24 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing an implantable polymeric medical device |
US20060292690A1 (en) * | 2005-06-22 | 2006-12-28 | Cesco Bioengineering Co., Ltd. | Method of making cell growth surface |
US7658880B2 (en) * | 2005-07-29 | 2010-02-09 | Advanced Cardiovascular Systems, Inc. | Polymeric stent polishing method and apparatus |
US7297758B2 (en) * | 2005-08-02 | 2007-11-20 | Advanced Cardiovascular Systems, Inc. | Method for extending shelf-life of constructs of semi-crystallizable polymers |
US20070038290A1 (en) * | 2005-08-15 | 2007-02-15 | Bin Huang | Fiber reinforced composite stents |
US7476245B2 (en) * | 2005-08-16 | 2009-01-13 | Advanced Cardiovascular Systems, Inc. | Polymeric stent patterns |
US9248034B2 (en) | 2005-08-23 | 2016-02-02 | Advanced Cardiovascular Systems, Inc. | Controlled disintegrating implantable medical devices |
US20070045252A1 (en) * | 2005-08-23 | 2007-03-01 | Klaus Kleine | Laser induced plasma machining with a process gas |
US20070045255A1 (en) * | 2005-08-23 | 2007-03-01 | Klaus Kleine | Laser induced plasma machining with an optimized process gas |
US8187318B2 (en) * | 2005-08-31 | 2012-05-29 | Advanced Bio Prosthetic Surfaces, Ltd. | Covered stent with proximal and distal attachment, delivery catheter, and method of making same |
US7670369B2 (en) * | 2005-10-13 | 2010-03-02 | Cook Incorporated | Endoluminal prosthesis |
US8163002B2 (en) * | 2005-11-14 | 2012-04-24 | Vascular Devices Llc | Self-sealing vascular graft |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US20070148251A1 (en) * | 2005-12-22 | 2007-06-28 | Hossainy Syed F A | Nanoparticle releasing medical devices |
US20070151961A1 (en) * | 2006-01-03 | 2007-07-05 | Klaus Kleine | Fabrication of an implantable medical device with a modified laser beam |
US20070156230A1 (en) | 2006-01-04 | 2007-07-05 | Dugan Stephen R | Stents with radiopaque markers |
US7951185B1 (en) | 2006-01-06 | 2011-05-31 | Advanced Cardiovascular Systems, Inc. | Delivery of a stent at an elevated temperature |
US8900287B2 (en) * | 2006-01-13 | 2014-12-02 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm |
US20070179219A1 (en) * | 2006-01-31 | 2007-08-02 | Bin Huang | Method of fabricating an implantable medical device using gel extrusion and charge induced orientation |
US8828091B2 (en) * | 2006-03-23 | 2014-09-09 | Boston Scientific Scimed, Inc. | Movable stent reinforcement |
US7964210B2 (en) * | 2006-03-31 | 2011-06-21 | Abbott Cardiovascular Systems Inc. | Degradable polymeric implantable medical devices with a continuous phase and discrete phase |
US20070254012A1 (en) * | 2006-04-28 | 2007-11-01 | Ludwig Florian N | Controlled degradation and drug release in stents |
US8003156B2 (en) * | 2006-05-04 | 2011-08-23 | Advanced Cardiovascular Systems, Inc. | Rotatable support elements for stents |
US7761968B2 (en) * | 2006-05-25 | 2010-07-27 | Advanced Cardiovascular Systems, Inc. | Method of crimping a polymeric stent |
US20130325104A1 (en) | 2006-05-26 | 2013-12-05 | Abbott Cardiovascular Systems Inc. | Stents With Radiopaque Markers |
US7951194B2 (en) | 2006-05-26 | 2011-05-31 | Abbott Cardiovascular Sysetms Inc. | Bioabsorbable stent with radiopaque coating |
US7842737B2 (en) | 2006-09-29 | 2010-11-30 | Abbott Cardiovascular Systems Inc. | Polymer blend-bioceramic composite implantable medical devices |
US7959940B2 (en) * | 2006-05-30 | 2011-06-14 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical devices |
US20070282434A1 (en) * | 2006-05-30 | 2007-12-06 | Yunbing Wang | Copolymer-bioceramic composite implantable medical devices |
US8343530B2 (en) * | 2006-05-30 | 2013-01-01 | Abbott Cardiovascular Systems Inc. | Polymer-and polymer blend-bioceramic composite implantable medical devices |
US20080058916A1 (en) * | 2006-05-31 | 2008-03-06 | Bin Huang | Method of fabricating polymeric self-expandable stent |
US20070282433A1 (en) * | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US8486135B2 (en) | 2006-06-01 | 2013-07-16 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from branched polymers |
US8034287B2 (en) * | 2006-06-01 | 2011-10-11 | Abbott Cardiovascular Systems Inc. | Radiation sterilization of medical devices |
US20070281073A1 (en) * | 2006-06-01 | 2007-12-06 | Gale David C | Enhanced adhesion of drug delivery coatings on stents |
US20080124372A1 (en) * | 2006-06-06 | 2008-05-29 | Hossainy Syed F A | Morphology profiles for control of agent release rates from polymer matrices |
US20070286941A1 (en) * | 2006-06-13 | 2007-12-13 | Bin Huang | Surface treatment of a polymeric stent |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) * | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8535372B1 (en) | 2006-06-16 | 2013-09-17 | Abbott Cardiovascular Systems Inc. | Bioabsorbable stent with prohealing layer |
US20070290412A1 (en) * | 2006-06-19 | 2007-12-20 | John Capek | Fabricating a stent with selected properties in the radial and axial directions |
US8333000B2 (en) | 2006-06-19 | 2012-12-18 | Advanced Cardiovascular Systems, Inc. | Methods for improving stent retention on a balloon catheter |
US8017237B2 (en) * | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
US9072820B2 (en) * | 2006-06-26 | 2015-07-07 | Advanced Cardiovascular Systems, Inc. | Polymer composite stent with polymer particles |
US8128688B2 (en) * | 2006-06-27 | 2012-03-06 | Abbott Cardiovascular Systems Inc. | Carbon coating on an implantable device |
US20070299511A1 (en) * | 2006-06-27 | 2007-12-27 | Gale David C | Thin stent coating |
US7794776B1 (en) | 2006-06-29 | 2010-09-14 | Abbott Cardiovascular Systems Inc. | Modification of polymer stents with radiation |
US7740791B2 (en) * | 2006-06-30 | 2010-06-22 | Advanced Cardiovascular Systems, Inc. | Method of fabricating a stent with features by blow molding |
US20080009938A1 (en) * | 2006-07-07 | 2008-01-10 | Bin Huang | Stent with a radiopaque marker and method for making the same |
US7823263B2 (en) | 2006-07-11 | 2010-11-02 | Abbott Cardiovascular Systems Inc. | Method of removing stent islands from a stent |
US20080014244A1 (en) * | 2006-07-13 | 2008-01-17 | Gale David C | Implantable medical devices and coatings therefor comprising physically crosslinked block copolymers |
US7998404B2 (en) * | 2006-07-13 | 2011-08-16 | Advanced Cardiovascular Systems, Inc. | Reduced temperature sterilization of stents |
US7757543B2 (en) | 2006-07-13 | 2010-07-20 | Advanced Cardiovascular Systems, Inc. | Radio frequency identification monitoring of stents |
US7794495B2 (en) * | 2006-07-17 | 2010-09-14 | Advanced Cardiovascular Systems, Inc. | Controlled degradation of stents |
US7886419B2 (en) * | 2006-07-18 | 2011-02-15 | Advanced Cardiovascular Systems, Inc. | Stent crimping apparatus and method |
US20080091262A1 (en) * | 2006-10-17 | 2008-04-17 | Gale David C | Drug delivery after biodegradation of the stent scaffolding |
US8016879B2 (en) * | 2006-08-01 | 2011-09-13 | Abbott Cardiovascular Systems Inc. | Drug delivery after biodegradation of the stent scaffolding |
US9173733B1 (en) | 2006-08-21 | 2015-11-03 | Abbott Cardiovascular Systems Inc. | Tracheobronchial implantable medical device and methods of use |
US7923022B2 (en) * | 2006-09-13 | 2011-04-12 | Advanced Cardiovascular Systems, Inc. | Degradable polymeric implantable medical devices with continuous phase and discrete phase |
US8099849B2 (en) | 2006-12-13 | 2012-01-24 | Abbott Cardiovascular Systems Inc. | Optimizing fracture toughness of polymeric stent |
US20080243228A1 (en) * | 2007-03-28 | 2008-10-02 | Yunbing Wang | Implantable medical devices fabricated from block copolymers |
US8262723B2 (en) | 2007-04-09 | 2012-09-11 | Abbott Cardiovascular Systems Inc. | Implantable medical devices fabricated from polymer blends with star-block copolymers |
US7829008B2 (en) * | 2007-05-30 | 2010-11-09 | Abbott Cardiovascular Systems Inc. | Fabricating a stent from a blow molded tube |
US9144509B2 (en) * | 2007-05-31 | 2015-09-29 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US9149610B2 (en) | 2007-05-31 | 2015-10-06 | Abbott Cardiovascular Systems Inc. | Method and apparatus for improving delivery of an agent to a kidney |
US8216209B2 (en) | 2007-05-31 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US9364586B2 (en) * | 2007-05-31 | 2016-06-14 | Abbott Cardiovascular Systems Inc. | Method and apparatus for improving delivery of an agent to a kidney |
US7959857B2 (en) * | 2007-06-01 | 2011-06-14 | Abbott Cardiovascular Systems Inc. | Radiation sterilization of medical devices |
US8293260B2 (en) | 2007-06-05 | 2012-10-23 | Abbott Cardiovascular Systems Inc. | Elastomeric copolymer coatings containing poly (tetramethyl carbonate) for implantable medical devices |
US8202528B2 (en) * | 2007-06-05 | 2012-06-19 | Abbott Cardiovascular Systems Inc. | Implantable medical devices with elastomeric block copolymer coatings |
US20100070020A1 (en) | 2008-06-11 | 2010-03-18 | Nanovasc, Inc. | Implantable Medical Device |
US8425591B1 (en) | 2007-06-11 | 2013-04-23 | Abbott Cardiovascular Systems Inc. | Methods of forming polymer-bioceramic composite medical devices with bioceramic particles |
JP5734650B2 (en) * | 2007-06-25 | 2015-06-17 | マイクロベンション インコーポレイテッド | Self-expanding prosthesis |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
US7901452B2 (en) * | 2007-06-27 | 2011-03-08 | Abbott Cardiovascular Systems Inc. | Method to fabricate a stent having selected morphology to reduce restenosis |
US7955381B1 (en) | 2007-06-29 | 2011-06-07 | Advanced Cardiovascular Systems, Inc. | Polymer-bioceramic composite implantable medical device with different types of bioceramic particles |
US7979108B2 (en) * | 2007-08-27 | 2011-07-12 | William Harrison Zurn | Automated vessel repair system, devices and methods |
US20090088833A1 (en) * | 2007-09-28 | 2009-04-02 | Maximiliano Soetermans | Double wall stent with retrieval member |
US8196279B2 (en) * | 2008-02-27 | 2012-06-12 | C. R. Bard, Inc. | Stent-graft covering process |
US20110295181A1 (en) | 2008-03-05 | 2011-12-01 | Hemosphere, Inc. | Implantable and removable customizable body conduit |
US8709096B2 (en) | 2008-04-29 | 2014-04-29 | Proxy Biomedical Limited | Tissue repair implant |
US9402707B2 (en) | 2008-07-22 | 2016-08-02 | Neuravi Limited | Clot capture systems and associated methods |
AU2009318772B2 (en) | 2008-11-24 | 2016-05-19 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | External stent |
US20100228337A1 (en) * | 2009-03-04 | 2010-09-09 | Abbott Laboratories Vascular Enterprises Limited | Mirror image stent and method of use |
US9492587B2 (en) * | 2009-04-13 | 2016-11-15 | Abbott Cardiovascular Systems Inc. | Stent made from an ultra high molecular weight bioabsorbable polymer with high fatigue and fracture resistance |
US8568471B2 (en) | 2010-01-30 | 2013-10-29 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds |
US8808353B2 (en) | 2010-01-30 | 2014-08-19 | Abbott Cardiovascular Systems Inc. | Crush recoverable polymer scaffolds having a low crossing profile |
US9463036B2 (en) | 2010-10-22 | 2016-10-11 | Neuravi Limited | Clot engagement and removal system |
US11259824B2 (en) | 2011-03-09 | 2022-03-01 | Neuravi Limited | Clot retrieval device for removing occlusive clot from a blood vessel |
WO2012120490A2 (en) | 2011-03-09 | 2012-09-13 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
US10052218B2 (en) | 2011-04-18 | 2018-08-21 | Vascular Graft Solutions Ltd. | Devices and methods for deploying implantable sleeves over blood vessels |
CA2835427A1 (en) | 2011-05-11 | 2012-11-15 | Microvention, Inc. | Device for occluding a lumen |
US8726483B2 (en) | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
CN103813817A (en) | 2011-09-06 | 2014-05-21 | 海默斯菲尔有限公司 | Vascular access system with connector |
US8663209B2 (en) | 2012-01-24 | 2014-03-04 | William Harrison Zurn | Vessel clearing apparatus, devices and methods |
US9833207B2 (en) | 2012-08-08 | 2017-12-05 | William Harrison Zurn | Analysis and clearing module, system and method |
US9962533B2 (en) | 2013-02-14 | 2018-05-08 | William Harrison Zurn | Module for treatment of medical conditions; system for making module and methods of making module |
US9610179B2 (en) * | 2013-03-12 | 2017-04-04 | Cook Medical Technologies Llc | Atraumatic stent crowns |
SI2967610T1 (en) * | 2013-03-14 | 2019-07-31 | Neuravi Limited | A clot retrieval device for removing occlusive clot from a blood vessel |
US9433429B2 (en) | 2013-03-14 | 2016-09-06 | Neuravi Limited | Clot retrieval devices |
TR201901830T4 (en) | 2013-03-14 | 2019-03-21 | Neuravi Ltd | Devices and methods for the removal of acute blockages from blood vessels. |
US9814560B2 (en) | 2013-12-05 | 2017-11-14 | W. L. Gore & Associates, Inc. | Tapered implantable device and methods for making such devices |
US10617435B2 (en) | 2014-11-26 | 2020-04-14 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
JP2017535352A (en) | 2014-11-26 | 2017-11-30 | ニューラヴィ・リミテッド | Clot collection device for removing obstructive clots from blood vessels |
US11253278B2 (en) | 2014-11-26 | 2022-02-22 | Neuravi Limited | Clot retrieval system for removing occlusive clot from a blood vessel |
US9999527B2 (en) | 2015-02-11 | 2018-06-19 | Abbott Cardiovascular Systems Inc. | Scaffolds having radiopaque markers |
EP3302619A1 (en) | 2015-06-05 | 2018-04-11 | W. L. Gore & Associates, Inc. | A low bleed implantable prosthesis with a taper |
US9700443B2 (en) | 2015-06-12 | 2017-07-11 | Abbott Cardiovascular Systems Inc. | Methods for attaching a radiopaque marker to a scaffold |
US10130465B2 (en) | 2016-02-23 | 2018-11-20 | Abbott Cardiovascular Systems Inc. | Bifurcated tubular graft for treating tricuspid regurgitation |
CA3031569C (en) | 2016-08-08 | 2021-03-16 | W. L. Gore & Associates, Inc. | Kink resistant graft |
MX2019002565A (en) | 2016-09-06 | 2019-09-18 | Neuravi Ltd | A clot retrieval device for removing occlusive clot from a blood vessel. |
US11911585B2 (en) | 2017-07-20 | 2024-02-27 | Merit Medical Systems, Inc. | Methods and systems for coupling conduits |
WO2019089569A1 (en) * | 2017-10-31 | 2019-05-09 | Merit Medical Systems, Inc. | Subcutaneous vascular assemblies for improving blood flow and related devices and methods |
US10575973B2 (en) | 2018-04-11 | 2020-03-03 | Abbott Cardiovascular Systems Inc. | Intravascular stent having high fatigue performance |
US10842498B2 (en) | 2018-09-13 | 2020-11-24 | Neuravi Limited | Systems and methods of restoring perfusion to a vessel |
US11406416B2 (en) | 2018-10-02 | 2022-08-09 | Neuravi Limited | Joint assembly for vasculature obstruction capture device |
US11712231B2 (en) | 2019-10-29 | 2023-08-01 | Neuravi Limited | Proximal locking assembly design for dual stent mechanical thrombectomy device |
US11517340B2 (en) | 2019-12-03 | 2022-12-06 | Neuravi Limited | Stentriever devices for removing an occlusive clot from a vessel and methods thereof |
US11871946B2 (en) | 2020-04-17 | 2024-01-16 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11717308B2 (en) | 2020-04-17 | 2023-08-08 | Neuravi Limited | Clot retrieval device for removing heterogeneous clots from a blood vessel |
US11730501B2 (en) | 2020-04-17 | 2023-08-22 | Neuravi Limited | Floating clot retrieval device for removing clots from a blood vessel |
US11737771B2 (en) | 2020-06-18 | 2023-08-29 | Neuravi Limited | Dual channel thrombectomy device |
US11937836B2 (en) | 2020-06-22 | 2024-03-26 | Neuravi Limited | Clot retrieval system with expandable clot engaging framework |
US11439418B2 (en) | 2020-06-23 | 2022-09-13 | Neuravi Limited | Clot retrieval device for removing clot from a blood vessel |
US11395669B2 (en) | 2020-06-23 | 2022-07-26 | Neuravi Limited | Clot retrieval device with flexible collapsible frame |
US11864781B2 (en) | 2020-09-23 | 2024-01-09 | Neuravi Limited | Rotating frame thrombectomy device |
US11937837B2 (en) | 2020-12-29 | 2024-03-26 | Neuravi Limited | Fibrin rich / soft clot mechanical thrombectomy device |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3187752A (en) * | 1962-04-27 | 1965-06-08 | American Cyanamid Co | Non-absorbable silicone coated sutures and method of making |
GB1104680A (en) * | 1965-10-18 | 1968-02-28 | Univ Birmingham | Artificial artery |
US3479670A (en) * | 1966-10-19 | 1969-11-25 | Ethicon Inc | Tubular prosthetic implant having helical thermoplastic wrapping therearound |
US3688317A (en) * | 1970-08-25 | 1972-09-05 | Sutures Inc | Vascular prosthetic |
US4281669A (en) * | 1975-05-09 | 1981-08-04 | Macgregor David C | Pacemaker electrode with porous system |
US4130904A (en) * | 1977-06-06 | 1978-12-26 | Thermo Electron Corporation | Prosthetic blood conduit |
DE2806030C2 (en) * | 1978-02-14 | 1984-02-02 | B. Braun Melsungen Ag, 3508 Melsungen | Process for the production of a tubular blood vessel prosthesis |
DE3019996A1 (en) * | 1980-05-24 | 1981-12-03 | Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen | HOHLORGAN |
GB2115776B (en) * | 1982-03-02 | 1986-03-12 | Ontario Research Foundation | Implantable material |
US4475972A (en) * | 1981-10-01 | 1984-10-09 | Ontario Research Foundation | Implantable material |
EP0157178B1 (en) * | 1984-03-01 | 1988-11-30 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Artificial vessel and process for preparing the same |
US4629458A (en) * | 1985-02-26 | 1986-12-16 | Cordis Corporation | Reinforcing structure for cardiovascular graft |
US4743252A (en) * | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
EP0246638A3 (en) * | 1986-05-23 | 1989-03-15 | Cordis Corporation | Biologically modified synthetic grafts |
-
1989
- 1989-07-10 US US07/377,463 patent/US5084065A/en not_active Expired - Lifetime
-
1990
- 1990-01-11 CA CA002007562A patent/CA2007562A1/en not_active Abandoned
- 1990-04-02 EP EP90106254A patent/EP0407692A1/en not_active Withdrawn
- 1990-04-12 JP JP2097478A patent/JP2739878B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0407692A1 (en) | 1991-01-16 |
JP2739878B2 (en) | 1998-04-15 |
JPH0345251A (en) | 1991-02-26 |
US5084065A (en) | 1992-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2007562A1 (en) | Reinforced graft assembly | |
EP0051954B1 (en) | Structure for in vivo implantation | |
US6821295B1 (en) | Flared coronary artery bypass grafts | |
CN106456326B (en) | The method of artificial valve and manufacture of intraocular valve | |
JP4401165B2 (en) | Composite ePTFE / fiber prosthesis | |
US7887576B2 (en) | Endoluminal device with extracellular matrix material and methods | |
US3783454A (en) | Surgically implantable prosthetic duct for the removal of biological liquids | |
US4728328A (en) | Cuffed tubular organic prostheses | |
CA1207105A (en) | Arterial graft prosthesis | |
JPS6125454Y2 (en) | ||
AU2020201076A1 (en) | Inflatable balloon and cover | |
JPS6344382B2 (en) | ||
EP0227955A3 (en) | Composite wound dressing | |
CA2122716A1 (en) | Silicone/dracon composite vascular graft | |
JPH10258073A (en) | Implantable tubular artificial organ for soft tissue | |
JP2002540854A (en) | Pipe lining | |
EP1746952A1 (en) | Endoluminal device with extracellular matrix material and methods | |
WO2006038031A2 (en) | Synthetic prosthesis for aortic root replacement | |
CA2657707A1 (en) | Tissue compatible heart valve sewing ring | |
CN106604694A (en) | Migration-resistant gastrointestinal barrier with adhesive portion | |
JPH03502898A (en) | Self-blocking stem | |
EP1185313B1 (en) | Expanded polytetrafluoroethylene vascular graft with increased healing response | |
JPH0459901B2 (en) | ||
JPH06189984A (en) | Artificial blood vessel and manufacture thereof | |
JPH09512198A (en) | Orthotics and methods for protecting prosthetic joint assemblies from debris |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |